Document:

Prepared by R.R. Donnelley Financial -- EX-10.30

 Exhibit 10.30 

Virgin America Inc. 

Change in Control Severance Plan 

(and Summary Plan Description) 

Effective                     ,
2014 
 This Virgin America Inc. Change in Control Severance Plan (this “Plan”) was established effective as of
                    , 2014 (the “Effective Date”). The purpose of this Plan is to provide for severance benefits to certain
eligible employees of Virgin America Inc. (together with its subsidiaries or affiliates, the “Company”) whose employment with the Company is terminated under certain circumstances. 

This Plan is an employee welfare benefit plan subject to the Employee Retirement Income Security Act of 1974, as amended
(“ERISA”). This Plan document is also the summary plan description of this Plan. References in this Plan to “you” or “your” are references to a Covered Employee. Certain capitalized terms used in this Plan are
defined in Section 3 below. 
 1. General Eligibility. The eligible employees in this Plan are employees of the Company who are
employed at the level of Director or above (such eligible employees, the “Covered Employees”). Covered Employees remain eligible for this Plan in the case of sick leave, military leave or any other leave of absence approved pursuant
to the regular leave policy of the Company. 
 2. Change in Control Severance Benefits. If you are a Covered Employee and if the
Company terminates your employment with the Company without Cause (which, for the avoidance of doubt, excludes a termination due to your death or disability) or you terminate employment with the Company for Good Reason, in either case, during the
eighteen (18) month period immediately following a Change in Control (the “Change in Control Period”), then subject to Section 18(b) hereof and you delivering to the Company a general release of all claims against the
Company and its affiliates in a form acceptable to the Company that becomes effective and irrevocable within sixty (60) days following the date of such termination of employment, in addition to any accrued but unpaid salary, wages, vacation and
other amounts required by applicable law, you will be eligible to receive the following severance payments and benefits based upon your position or designation: 

a. Cash Severance. You will receive a severance payment in the amount calculated by multiplying (i) the sum of (x) your Base
Salary and (y) your target annual cash bonus opportunity for the fiscal year of your termination, times (ii) your Severance Multiplier, payable in a cash lump sum on the 60th day following the date of your termination of employment (the
“Termination Date”). 
 b. COBRA Premium Payment. Subject to the requirements of the Internal Revenue Code of 1986,
as amended (the “Code”), if you properly elect health care continuation coverage under the Company’s group health plans pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), to the
extent that you are eligible to do so, then the Company shall directly pay or, at its election, reimburse you for the COBRA premiums, for you and your covered dependents until the earliest of (i) the end of your Benefits Period; (ii) the
date you become eligible for healthcare under a subsequent employer’s health plan (of which eligibility you agree to give prompt notice to the Company); and (iii) the date you cease to be eligible for COBRA or any state law equivalent.
Notwithstanding the foregoing, (i) if any plan pursuant to which such benefits are provided is not, or ceases prior to the expiration of the period of continuation coverage to be, exempt from the application of Section 409A of the Code
under Treasury Regulation Section 1.409A-1(a)(5), or (ii) the Company is otherwise unable to continue to cover you under its group health plans without penalty under applicable law (including without limitation, Section 2716 of the
Public Health Service Act), then, in either case, an amount equal to each remaining Company subsidy shall thereafter be paid to you in substantially equal monthly installments over the Benefits Period (or the remaining portion thereof). 

 c. Accelerated Vesting of Equity Awards. Each outstanding Company equity award including,
without limitation, each stock option, restricted stock unit and restricted stock award, that you hold as of the date of termination shall automatically become vested and, if applicable, exercisable and any forfeiture restrictions or rights of
repurchase thereon shall immediately lapse, in each case, with respect to one-hundred percent (100%) of the unvested shares of Company common stock subject to such equity award. 

d. Career Counseling. You will be entitled to receive Company-paid career counseling and career transition consulting services in an
amount up to the Career Services Amount. 
 e. Travel Benefits. You will be entitled to receive the Travel Benefits. 

3. Definitions. For the purposes of this Plan, the following terms shall have the following meanings: 

a. “Base Salary” means your annual base salary in effect immediately prior to your termination (disregarding any reduction in
base salary that would give rise to your right to terminate for Good Reason). 
 b. “Benefits Period” shall mean that
period of time commencing upon the Termination Date and ending upon: (i) if you are at the level of Senior Vice President and above, the second (2nd) anniversary of the Termination Date;
and (ii) if you are at the level of Director or Vice President, the first (1st) anniversary of the Termination Date. 

c. “Career Services Amount” shall mean: (i) if you are at the level of Senior Vice President and above, ten thousand
dollars ($10,000); and (ii) if you are at the level of Director or Vice President, five thousand dollars ($5,000). 
 d.
“Cause” shall mean your (i) conviction of, or plea of no contest to, a felony or other crime involving moral turpitude or dishonesty; (ii) participation in a fraud or willful act of dishonesty against the Company that
adversely affects the Company in a material way; (iii) willful breach of the Company’s policies that affects the Company in a material way; (iv) causing intentional damage to the Company’s property or business; (v) repeated
neglect of your duties with the Company; provided, however, that for purposes of clause (v), no conduct will be deemed to constitute “Cause” unless (A) such conduct is committed in bad faith, without reasonable belief that the action
or inaction is in the best interests of the Company and (B) if such conduct is capable of being cured, until you have received prior written notice of the conduct, which persists after a 30-day cure period following the written notice; or
(vi) refusal to accept an offer of employment with the successor or survivor entity following a Change in Control that provides for substantially equivalent base pay and job responsibilities, in each case, as compared to your base pay and job
responsibilities in effect as of immediately prior to the Change in Control. 
 e. “Change in Control” shall have the
meaning set forth in the Company’s 2014 Equity Incentive Award Plan, as it may be amended from time to time. If a Change in Control constitutes a payment event with respect to any amount which constitutes or provides for the deferral of
compensation and is subject to Section 409A of the Code, the transaction or event with respect to such amount must also constitute a “change in control event,” as defined in Treasury Regulation Section 1.409A-3(i)(5) to the
extent required by Section 409A of the Code. 

  
 2 

 f. “Good Reason” shall mean the occurrence of any one of the following
conditions with respect to you without your prior written consent: (i) a material diminution in your base salary; (ii) a significant diminution of your position, responsibilities or duties; or (iii) a material change in geographic
location at which you must perform services on behalf of the Company (for this purpose, a change in any such location will be considered material only if it increases your current one-way commute by more than fifty (50) miles). Notwithstanding
the foregoing, you will not be deemed to have Good Reason unless: (x) you provide the Company with written notice of the event or condition giving rise to Good Reason within ninety (90) days following the initial occurrence thereof;
(y) the Company does not reverse or otherwise cure the event or condition within thirty (30) days of receiving that written notice; and (z) you resign your employment within thirty (30) days following the expiration of such cure
period. 
 g. “Plan Administrator” means the compensation committee of the board of directors of the Company (the
“Board”) or any committee designated by the Board to administer the Plan. 
 h. “Severance Multiplier”
shall mean: (i) if you are at the level of Senior Vice President or above, two (2); and (ii) if you are at the level of Director or Vice President, one (1). 

i. “Travel Benefits” shall mean: (i) if you are at the level of Senior Vice President or above, lifetime positive space
first class air travel for yourself, covered family members and dependents for leisure travel; and (ii) if you are at the level of Director or Vice President, for five (5) years following the Termination Date, positive space economy air
travel for yourself, covered family members and dependents for leisure travel, in each case, subject to the Company’s travel benefit policy as in effect from time to time. 

4. Claw-back. Any payments or benefits provided hereunder shall be subject to the provisions of any claw-back policy implemented by the
Company, including without limitation, any claw-back policy adopted to comply with the requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act and any rules or regulations promulgated thereunder. 

5. Taxes. All payments to be made under this Plan will be subject to appropriate tax withholding and other deductions. 

6. Best Pay Provision. 

a. Notwithstanding any other provisions of this Plan, in the event that any payment or benefit received or to be received by the Covered
Employee (whether pursuant to the terms of this Plan or any other plan, arrangement or agreement) (all such payments and benefits, including the payments and benefits under Section 2 of this Plan, being hereinafter referred to as the
“Total Payments”) would be subject (in whole or part), to the excise tax imposed under Section 4999 of the Code (the “Excise Tax”), then, after taking into account any reduction in the Total Payments provided
by reason of Section 280G of the Code in such other plan, arrangement or agreement, the Total Payments shall be reduced to the extent necessary so that no portion of the Total Payments is subject to the Excise Tax but only if (i) the net
amount of such Total Payments, as so reduced (and after subtracting the net amount of federal, state and local income taxes on such reduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions
attributable to such reduced Total Payments) is greater than or equal to (ii) the net amount of such Total Payments without such reduction (but after subtracting the net amount of federal, state and local income taxes on such Total Payments and
the amount of Excise Tax to which the Covered Employee would be subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such unreduced Total
Payments). The Total Payments shall be reduced in the following order: (A) reduction of any cash severance payments otherwise payable to the Covered Employee that are exempt from 

  
 3 

 
Section 409A of the Code, (B) reduction of any other cash payments or benefits otherwise payable to the Covered Employee that are exempt from Section 409A of the Code, but
excluding any payment attributable to the acceleration of vesting or payment with respect to any stock option or other equity award with respect to the Company common stock that are exempt from Section 409A of the Code, (C) reduction of
any other payments or benefits otherwise payable to the Covered Employee on a pro-rata basis or such other manner that complies with Section 409A of the Code, but excluding any payment attributable to the acceleration of vesting and payment
with respect to any stock option or other equity award with respect to the Company common stock that are exempt from Section 409A of the Code, and (D) reduction of any payments attributable to the acceleration of vesting or payment with
respect to any stock option or other equity award with respect to the Company common stock that are exempt from Section 409A of the Code. The foregoing reductions shall be made in a manner that results in the maximum economic benefit to
the Covered Employee and, to the extent economically equivalent, in a pro rata manner. 
 b. For purposes of determining whether and the
extent to which the Total Payments will be subject to the Excise Tax, (i) no portion of the Total Payments the receipt or enjoyment of which the Covered Employee shall have waived at such time and in such manner as not to constitute a
“payment” within the meaning of Section 280G(b) of the Code shall be taken into account, (ii) no portion of the Total Payments shall be taken into account which, in the written opinion of an accounting firm or compensation
consulting firm with nationally recognized standing and substantial expertise and experience on Section 280G matters (the “280G Firm”) selected by the Company, does not constitute a “parachute payment” within the
meaning of Section 280G(b)(2) of the Code (including by reason of Section 280G(b)(4)(A) of the Code) and, in calculating the Excise Tax, no portion of such Total Payments shall be taken into account which, in the opinion of the 280G Firm,
constitutes reasonable compensation for services actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the Base Amount (as defined in Section 280G(b)(3) of the Code) allocable to such reasonable
compensation, and (iii) the value of any non-cash benefit or any deferred payment or benefit included in the Total Payments shall be determined by the 280G Firm in accordance with the principles of Sections 280G(d)(3) and (4) of the Code.

 c. The 280G Firm will be directed to submit its determination and detailed supporting calculations to both the Covered Employee and the
Company within fifteen (15) days after notification from either the Company or the Covered Employee that the Covered Employee may receive payments which may be “parachute payments.” The Covered Employee and the Company will each
provide the 280G Firm access to and copies of any books, records and documents in their possession as may be reasonably requested by the 280G Firm, and otherwise cooperate with the 280G Firm in connection with the preparation and issuance of the
determinations and calculations contemplated by this Section 5(c). The fees and expenses of the 280G Firm for its services in connection with the determinations and calculations contemplated by this Section 6(c) will be borne by the
Company. 
 7. Amendment of Plan. Prior to the consummation of a Change in Control, the Plan Administrator shall have the power to
amend or terminate this Plan from time to time in its discretion and for any reason (or no reason); provided that no such amendment or termination shall be effective with respect to a termination of employment that occurred prior to the amendment or
termination. Notwithstanding the foregoing, during a Change in Control Period, no amendment or termination of the Plan shall impair any rights or obligations to any Covered Employee under this Plan unless such Covered Employee expressly consents to
such amendment or termination. 

  
 4 

 8. Claims Procedures. 

a. Normally, you do not need to present a formal claim to receive benefits payable under this Plan. 

b. If any person (the “Claimant”) believes that benefits are being denied improperly, that this Plan is not being operated
properly, that fiduciaries of this Plan have breached their duties, or that the Claimant’s legal rights are being violated with respect to this Plan, the Claimant must file a formal claim, in writing, with the Plan Administrator. This
requirement applies to all claims that any Claimant has with respect to this Plan, including claims against fiduciaries and former fiduciaries, except to the extent the Plan Administrator determines, in its sole discretion that it does not have the
power to grant all relief reasonably being sought by the Claimant. 
 c. A formal claim must be filed within ninety (90) days after the
date the Claimant first knew or should have known of the facts on which the claim is based, unless the Plan Administrator in writing consents otherwise. The Plan Administrator shall provide a Claimant, on request, with a copy of the claims
procedures established under subsection (d). 
 d. The Plan Administrator has adopted procedures for considering claims (which are set forth
in Appendix A attached hereto), which it may amend from time to time, as it sees fit. These procedures shall comply with all applicable legal requirements. These procedures may provide that final and binding arbitration shall be the ultimate means
of contesting a denied claim (even if the Plan Administrator or its delegates have failed to follow the prescribed procedures with respect to the claim). The right to receive benefits under this Plan is contingent on a Claimant using the prescribed
claims and arbitration procedures to resolve any claim. 
 9. Plan Administration. 

a. The Plan Administrator is responsible for the general administration and management of this Plan and shall have all powers and duties
necessary to fulfill its responsibilities, including, but not limited to, the discretion to interpret and apply this Plan and to determine all questions relating to eligibility for benefits. This Plan shall be interpreted in accordance with its
terms and their intended meanings. However, the Plan Administrator and all Plan fiduciaries shall have the discretion to interpret or construe ambiguous, unclear or implied (but omitted) terms in any fashion they deem to be appropriate in their sole
discretion, and to make any findings of fact needed in the administration of this Plan. The validity of any such interpretation, construction, decision or finding of fact shall not be given de novo review if challenged in court, by arbitration, or
in any other forum, and shall be upheld unless clearly arbitrary or capricious. 
 b. All actions taken and all determinations made in good
faith by the Plan Administrator or by Plan fiduciaries will be final and binding on all persons claiming any interest in or under this Plan. To the extent the Plan Administrator or any Plan fiduciary has been granted discretionary authority under
this Plan, the Plan Administrator’s or Plan fiduciary’s prior exercise of such authority shall not obligate it to exercise its authority in a like fashion thereafter. 

c. If, due to errors in drafting, any Plan provision does not accurately reflect its intended meaning, as demonstrated by consistent
interpretations or other evidence of intent, or as determined by the Plan Administrator in its sole discretion, the provision shall be considered ambiguous and shall be interpreted by the Plan Administrator and all Plan fiduciaries in a fashion
consistent with its intent, as determined in the sole discretion of the Plan Administrator. The Plan Administrator shall amend this Plan retroactively to cure any such ambiguity. 

  
 5 

 d. No Plan fiduciary shall have the authority to answer questions about any pending or final
business decision of the Company or any affiliate that has not been officially announced, to make disclosures about such matters, or even to discuss them, and no person shall rely on any unauthorized, unofficial disclosure. Thus, before a decision
is officially announced, no fiduciary is authorized to tell any employee, for example, that the employee will or will not be laid off or that the Company will or will not offer exit incentives in the future. Nothing in this subsection shall preclude
any fiduciary from fully participating in the consideration, making or official announcement of any business decision. 
 e. This
Section 9 may not be invoked by any person to require this Plan to be interpreted in a manner inconsistent with its interpretation by the Plan Administrator or other Plan fiduciaries. 

10. Funding and Payment of Benefits. This Plan shall be maintained in a manner to be considered “unfunded” for
purposes of ERISA. The Company shall be required to make payments only as benefits become due and payable. No person shall have any right, other than the right of an unsecured general creditor against the Company, with respect to the benefits
payable hereunder, or which may be payable hereunder, to any Covered Employee, surviving spouse or beneficiary hereunder. If the Company, acting in its sole discretion, establishes a reserve or other fund associated with this Plan, no person shall
have any right to or interest in any specific amount or asset of such reserve or fund by reason of amounts which may be payable to such person under this Plan, nor shall such person have any right to receive any payment under this Plan except as and
to the extent expressly provided in this Plan. The assets in any such reserve or fund shall be part of the general assets of the Company, subject to the control of the Company. 

11. Plan Application. This Plan shall be the only plan, agreement or arrangement with respect to which separation benefits may be
provided to a Covered Employee upon a termination of a Covered Employee’s employment within eighteen (18) months following a Change in Control and supersedes all prior agreements, arrangements or related communications of the Company
relating to such separation benefits for the Covered Employees, whether formal or informal, or written or unwritten. However, if a prior plan or agreement requires the consent of the employee in order for such prior plan or agreement to be modified
or amended or superseded by this Plan, such consent must be obtained from such employee in order for this Plan to supersede such prior plan or agreement. Subject to the foregoing, any benefits under this Plan will be provided to Covered Employees in
lieu of benefits under any other separation plan or agreement. 
 12. Successors. Any successor to the Company (whether direct or
indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets shall assume the obligations under this Plan and agree expressly to perform any of the
Company’s obligations under this Plan. For all purposes under this Plan, the term “Company” shall include any successor to the Company’s business and/or assets which executes and delivers an assumption agreement or which becomes
bound by the terms of the Plan by operation of law. All of your rights hereunder shall inure to the benefit of, and be enforceable by, your personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and
legatees. 
 13. Limitation On Employee Rights; At-Will Employment. This Plan shall not give any employee the right to be
retained in the service of the Company or interfere with or restrict the right of the Company to discharge or retire the employee. All employees of the Company are employed at will. 

14. No Third-Party Beneficiaries. This Plan shall not give any rights or remedies to any person other than Covered Employees and
the Company. 

  
 6 

 15. Governing Law. This Plan is a welfare plan subject to ERISA and it shall be
interpreted, administered, and enforced in accordance with that law. To the extent that state law is applicable, the statutes and common law of the jurisdiction in which the Covered Employee resides shall apply, excluding any that mandate the use of
another jurisdiction’s laws. 
 16. No Assignment of Benefits. The rights of any person to payments or benefits under
this Plan shall not be made subject to option or assignment, either by voluntary or involuntary assignment or by operation of law, including (without limitation) bankruptcy, garnishment, attachment or other creditor’s process, and any action in
violation of this subsection shall be void. 
 17. Miscellaneous. Where the context so indicates, the singular will include
the plural and vice versa. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Plan. Unless the context clearly indicates to the contrary, a reference to a statute or document
shall be construed as referring to any subsequently enacted, adopted or executed counterpart. 
 18. Section 409A. 

a. Separation from Service. Notwithstanding anything in this Plan to the contrary, any compensation or benefits payable under this Plan
that constitutes “nonqualified deferred compensation” within the meaning of Section 409A of the Code (“Deferred Compensation”), and which is designated under this Plan as payable upon your termination of employment
shall be payable only upon your “separation from service” with the Company within the meaning of Section 409A of the Code (a “Separation from Service”). 

b. Specified Employees. Notwithstanding any provision herein to the contrary, if you are deemed by the Company at the time of your
Separation from Service to be a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the benefits to which you are entitled under this Plan is required in
order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, such portion of your benefits shall not be provided to you prior to the earlier of (i) the expiration of the six-month period measured from the date of
your Separation from Service or (ii) the date of your death. Upon the first business day following the expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to the preceding sentence shall be
paid in a lump sum to you (or your estate or beneficiaries), and any remaining payments due to you under this Plan shall be paid as otherwise provided herein. 

c. Installments. Your right to receive any installment payments under this Plan shall be treated as a right to receive a series of
separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment as permitted under Treasury Regulation Section 1.409A-2(b)(2)(iii). 

d. General. To the extent applicable, this Plan shall be interpreted in accordance with, and incorporate the terms and conditions
required by, Section 409A of the Code and Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the adoption of this
Plan. Notwithstanding any provision of this Plan to the contrary, in the event that the Company determines that any amounts payable hereunder will be immediately taxable to you under Section 409A of the Code and related Department of Treasury
guidance, to the extent permitted under Section 409A of the Code, the Company may, to the extent permitted under Section 409A of the Code (i) cooperate in good faith to adopt such amendments to this Plan and appropriate policies and
procedures, including amendments and policies with retroactive effect, that they determine necessary or appropriate to preserve the intended tax treatment 

  
 7 

 
of the benefits provided by this Plan, preserve the economic benefits of this Plan and/or (ii) take such other actions as mutually determined necessary or appropriate to exempt the amounts
payable hereunder from Section 409A of the Code or to comply with the requirements of Section 409A of the Code and thereby avoid the application of penalty taxes under such section. To the extent applicable, each of the exceptions to Code
Section 409A’s prohibition on acceleration of payments of Deferred Compensation provided under Treasury Regulation 1.409A-3(j)(4) shall be permitted under the Agreement. 

  
 8 

 APPENDIX A 

Detailed Claims and Arbitration Procedures 
  

	 	1.	Claims Procedure 

 Initial Claims 

All claims shall be presented to the Plan Administrator in writing. Within ninety (90) days after receiving a claim, a claims official
appointed by the Plan Administrator shall consider the claim and issue his or her determination thereon in writing. If the Plan Administrator or claims official determines that an extension of time is necessary, the claims official may extend the
determination period for up to an additional ninety (90) days by giving the Claimant written notice indicating the special circumstances requiring the extension of time prior to the termination of the initial ninety (90) day period. Any
claims that the Claimant does not pursue in good faith through the initial claims stage shall be treated as having been irrevocably waived. 

Claims Decisions 
 If the
claim is granted, the benefits or relief the Claimant seeks shall be provided. If the claim is wholly or partially denied, the claims official shall, within ninety (90) days (or a longer period, as described above), provide the Claimant with
written notice of the denial, setting forth, in a manner calculated to be understood by the Claimant: (1) the specific reason or reasons for the denial; (2) specific references to the provisions on which the denial is based; (3) a
description of any additional material or information necessary for the Claimant to perfect the claim, together with an explanation of why the material or information is necessary; and (4) an explanation of the procedures for appealing denied
claims. If the Claimant can establish that the claims official has failed to respond to the claim in a timely manner, the Claimant may treat the claim as having been denied by the claims official. 

Appeals of Denied Claims 

Each Claimant shall have the opportunity to appeal the claims official’s denial of a claim in writing to an appeals official appointed by
the Plan Administrator (which may be a person, committee, or other entity). A Claimant must appeal a denied claim within sixty (60) days after receipt of written notice of denial of the claim, or within sixty (60) days after it was due if
the Claimant did not receive it by its due date. The Claimant shall have the opportunity to submit written comments, documents, records and other information relating to the Claimant’s claim. The Claimant (or the Claimant’s duly authorized
representative) shall be provided upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to the Claimant’s claim. The appeals official shall take into account during its
review all comments, documents, records and other information submitted by the Clamant relating to the claim, without regard to whether such information was submitted or considered in the initial benefits review. Any claims that the Claimant does
not pursue in good faith through the appeals stage, such as by failing to file a timely appeal request, shall be treated as having been irrevocably waived. 

Appeals Decisions 
 The
decision by the appeals official shall be made not later than sixty (60) days after the written appeal is received by the Plan Administrator, however, if the appeals official determines that an extension of time is necessary, the appeals
official may extend the determination period for up to an additional sixty (60) days by giving the Claimant written notice indicating the special circumstances 

  
 Appendix A-1 

 
requiring the extension of time prior to the termination of the initial sixty (60) day period. The appeal decision shall be in writing, shall be set forth in a manner calculated to be
understood by the Claimant and shall include the following: (1) the specific reason or reasons for the denial; (2) specific references to the provisions on which the denial is based; (3) a statement that the Claimant is entitled to
receive, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to the Claimant’s claim. If a Claimant does not receive the appeal decision by the date it is due, the Claimant
may deem the appeal to have been denied. 
 Procedures 

The Plan Administrator shall adopt procedures by which initial claims shall be considered and appeals shall be resolved; different procedures
may be established for different claims. All procedures shall be designed to afford a Claimant full and fair consideration of his or her claim. 

Arbitration of Rejected Appeals 

If a Claimant has pursued a claim through the appeal stage of these claims procedures, the Claimant may contest the actual or deemed denial of
that claim through arbitration, as described below. In no event shall any denied claim be subject to resolution by any means (such as in a court of law) other than arbitration in accordance with the following provisions. 

 

	 	2.	Arbitration Procedure 

 Request for Arbitration 

A Claimant must submit a request for arbitration to the Plan Administrator within sixty (60) days after receipt of the written denial of
an appeal (or within sixty (60) days after he or she should have received the determination). The Claimant or the Plan Administrator may bring an action in any court of appropriate jurisdiction to compel arbitration in accordance with these
procedures. 
 Applicable Arbitration Rules 

If the Claimant has entered into a valid arbitration agreement with the Company, the arbitration shall be conducted in accordance with that
agreement. If not, the rules set forth in the balance of this Appendix shall apply: The arbitration shall be held under the auspices of the Judicial Arbitration and Mediation Service (“JAMS”). Except as provided below, the arbitration
shall be in accordance with JAMS’ then-current employment dispute resolution rules. The Arbitrator shall apply the Federal Rules of Evidence and shall have the authority to entertain a motion to dismiss or a motion for summary judgment by any
party and shall apply the standards governing such motions under the Federal Rules of Civil Procedure. The Federal Arbitration Act shall govern all arbitrations that take place under these Detailed Claims and Arbitration Procedures (or that are
required to take place under them), and shall govern the interpretation or enforcement of these Procedures or any arbitration award. To the extent that the Federal Arbitration Act is inapplicable, California law pertaining to arbitration agreements
shall apply. 
 Arbitrator 

The arbitrator (the “Arbitrator”) shall be an attorney familiar with employee benefit matters who is licensed to practice law in the
state in which the arbitration is convened. The Arbitrator shall be selected in the following manner from a list of eleven arbitrators drawn by the sponsoring organization under whose auspices the arbitration is being conducted and taken from its
panel of labor and employment arbitrators. Each party shall designate all arbitrators on the list whom they find 

  
 Appendix A-2 

 
acceptable; the parties shall then alternately strike arbitrators from the list of arbitrators acceptable to both parties, with the party who did not initiate the arbitration striking first. If
only one arbitrator is acceptable to both parties, he or she will be the Arbitrator. If none of the arbitrators is acceptable to both parties, a new panel of arbitrators shall be obtained from the sponsoring organization and the selection process
shall be repeated. 
 Location 

The arbitration will take place in or near the city in which the Claimant is or was last employed by the Company or in which the Plan is
principally administered, whichever is specified by the Plan Administrator, or in such other location as may be acceptable to both the Claimant and the Plan Administrator. 

Authority of Arbitrator 

The Arbitrator shall have the authority to resolve any factual or legal claim relating to the Plan or relating to the interpretation,
applicability or enforceability of these arbitration procedures, including, but not limited to, any claim that these procedures are void or voidable. The Arbitrator may grant a Claimant’s claim only if the Arbitrator determines that it is
justified because: (1) the appeals official erred on an issue of law; or (2) the appeals official’s findings of fact, if applicable, were not supported by substantial evidence. The arbitration shall be final and binding on all
parties. 
 Limitation on Scope of Arbitration 

The Claimant may not present any evidence, facts, arguments or theories at the arbitration that the Claimant did not pursue in his or her
appeal, except in response to new evidence, facts, arguments or theories presented on behalf of the other parties to the arbitration. However, an arbitrator may permit a Claimant to present additional evidence or theories if the Arbitrator
determines that the Claimant was precluded from presenting them during the claim and appeal procedures due to procedural errors of the Plan Administrator or its delegates. 

Administrative Record 

The Plan Administrator shall submit to the Arbitrator a certified copy of the record on which the appeals official’s decision was made.

 Experts, Depositions, and Discovery 

Except as otherwise permitted by the Arbitrator on a showing of substantial need, either party may: (1) designate one expert witness;
(2) take the deposition of one individual and the other party’s expert witness; (3) propound requests for production of documents; and (4) subpoena witnesses and documents relating to the discovery permitted in this paragraph.

 Pre-Hearing Procedures 

At least thirty (30) days before the arbitration hearing, the parties must exchange lists of witnesses, including any expert witnesses,
and copies of all exhibits intended to be used at the hearing. The Arbitrator shall have jurisdiction to hear and rule on pre-hearing disputes and is authorized to hold pre-hearing conferences by telephone or in person, as the Arbitrator deems
necessary. 

  
 Appendix A-3 

 Transcripts 

Either party may arrange for a court reporter to provide a stenographic record of the proceedings at the party’s own cost. 

Post-Hearing Procedures 

Either party, on request at the close of the hearing, may be given leave to file a post-hearing brief within the time limits established by the
Arbitrator. 
 Costs and Attorneys’ Fees 

The Claimant and the Company shall equally share the fees and costs of the Arbitrator, except that the Claimant shall not be required to pay
any of the Arbitrator’s fees and costs if such a requirement would make mandatory arbitration under these procedures unenforceable. On a showing of material hardship, the Company, in its discretion, may advance all or part of the
Claimant’s share of the fees and costs, in which case the Claimant shall reimburse the Company out of the proceeds of the arbitration award, if any, that the Claimant receives. Each party shall pay its own costs and attorneys’ fees, except
as required by applicable law. 
 Procedure for Collecting Costs from Claimant 

Before the arbitration commences, the Claimant must deposit with the Plan Administrator his or her share of the anticipated fees and costs of
the Arbitrator, as reasonably determined by the Plan Administrator. At least two (2) weeks before delivering his or her decision, the Arbitrator shall send his or her final bill for fees and costs to the Plan Administrator for payment. The Plan
Administrator shall apply the amount deposited by the Claimant to pay the Claimant’s share of the Arbitrator’s fees and costs and return any surplus deposit. If the Claimant’s deposit is insufficient, the Claimant will be billed for
any remaining amount due. Failure to pay any amount within ten (10) days after it is billed shall constitute the Claimant’s irrevocable election to withdraw his or her arbitration request and abandon his or her claim. 

Arbitration Award 
 The
Arbitrator shall render an award and opinion in the form typically rendered in labor arbitrations. Within twenty (20) days after issuance of the Arbitrator’s award and opinion, either party may file with the Arbitrator a motion to
reconsider, which shall be accompanied by a supporting brief. If such a motion is filed, the other party shall have twenty (20) days from the date of the motion to respond, after which the Arbitrator shall reconsider the issues raised by the
motion and either promptly confirm or promptly change his or her decision. The decision shall then be final and conclusive on the parties. Arbitrator fees and other costs of a motion for reconsideration shall be borne by the losing party, unless the
Arbitrator orders otherwise. Either party may bring an action in any court of appropriate jurisdiction to enforce an arbitration award. A party opposing enforcement of an arbitration award may not do so in an enforcement proceeding, but must bring a
separate action in a court of competent jurisdiction to set aside the award. In any such action, the standard of review shall be the same as that applied by an appellate court reviewing the decision of a trial court in a nonjury trial. 

Severability 
 The
invalidity or unenforceability of any part of these arbitration procedures shall not affect the validity of the rest of the procedures. 

  
 Appendix A-4 

 APPENDIX B 

ADDITIONAL INFORMATION 

RIGHTS UNDER ERISA 
 As a
participant in the Plan, you are entitled to certain rights and protections under ERISA. ERISA provides that all Plan participants will be entitled to: 

Receive Information About Your Plan and Benefits 

1. Examine, without charge, at the Company’s headquarters, all documents governing the Plan including collective bargaining agreements, if
any, and annual reports and Plan descriptions. 
 2. Obtain, upon written request to the Plan Administrator, copies of documents governing
the operation of the Plan, including collective bargaining agreements, if any, and copies of the latest annual report (Form 5500 Series) and summary plan description. The Plan Administrator may make a reasonable charge for the copies. 

3. Receive a summary of the Plan’s annual financial report, if any. The Plan Administrator is required by law to furnish each participant
with a copy of this summary annual report. 
 Prudent Actions by Plan Fiduciaries 

In addition to creating rights for Plan participants, ERISA imposes duties upon the people who are responsible for the operation of the
employee benefit plan. The people who operate your Plan, called “fiduciaries” of the Plan, have a duty to do so prudently and in the interest of you and other Plan participants and beneficiaries. No one, including the Company, your union
or any other person, may fire you or otherwise discriminate against you in any way to prevent you from obtaining a welfare benefit or exercising your right under ERISA. 

Enforce Your Rights 
 If your claim
for a welfare benefit is denied or ignored, in whole or in part, you have a right to know why this was done, to obtain copies of documents relating to the decision without charge, and to appeal any denial, all within certain time schedules. Under
ERISA, there are steps you can take to enforce the above rights. For instance, if you request a copy of plan documents or the latest annual report from the Plan and do not receive them within thirty (30) days, you may file suit in a federal
court. In such a case, the court may require the Plan Administrator to provide the materials and pay you up to $110 a day until you receive the materials, unless the materials were not sent because of reasons beyond the control of the Plan
Administrator. If you have a claim for benefits, which is denied or ignored, in whole or in part, you may file suit in a state or federal court. In addition, if you disagree with the Plan’s decision or lack thereof concerning the qualified
status of a domestic relations order or a medical child support order, you may file suit in federal court. If it should happen that Plan fiduciaries misuse the Plan’s money, or if you are discriminated against for asserting your rights, you may
seek assistance from the U.S. Department of Labor, or you may file suit in a federal court. The court will decide who should pay court costs and legal fees. If you are successful, the court may order the person you have sued to pay these costs and
fees. If you lose, the court may order you to pay these costs and fees, for example, if it finds your claim is frivolous. 

  
 Appendix B-1 

 Assistance with Your Questions 

If you have any questions about your Plan, you should contact the Plan Administrator. If you should have any questions about this statement or
about your rights under ERISA, or if you need assistance in obtaining documents from the Plan Administrator, you should contact the nearest office of the Employee Benefits Security Administration, U.S. Department of Labor, listed in your
telephone directory or the Division of Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue N. W., Washington, D. C. 20210. You may also obtain certain publications about
your rights and responsibilities under ERISA by calling the publications hotline of the Employee Benefits Security Administration. 
 ADMINISTRATIVE
INFORMATION 
  

			
	 Name of Plan:
	  	Virgin America Inc. Change in Control Severance Plan
		
	 Plan Administrator and Sponsor:
	  	 Board of Directors
 Virgin America Inc.

555 Airport Boulevard
 Burlingame, CA 94010

Tel: (650) 762-7000

		
	 Type of Administration:
	  	Self-Administered
		
	 Type of Plan:
	  	Severance Pay Employee Welfare Benefit Plan
		
	 Employer Identification Number:
	  	20-1585173
		
	 Direct Questions Regarding the Plan

to:
	  	 Board of Directors
 Virgin America Inc.

555 Airport Boulevard
 Burlingame, CA 94010

Tel: (650) 762-7000

		
	 Agent for Service of Legal Process:
	  	 Secretary
 Virgin America Inc.

555 Airport Boulevard
 Burlingame, CA 94010

Tel: (650) 762-7000
 Service of Legal Process may also be made
upon the Plan
 Administrator.

		
	 Plan Year End:
	  	December 31

  
 Appendix B-2Prepared by R.R. Donnelley Financial -- EX-10.46

 Exhibit 10.46 

RECAPITALIZATION AGREEMENT 

dated as of                  , 2014 

by and among 
 VIRGIN AMERICA
INC., 
 VIRGIN MANAGEMENT LIMITED, 

VA HOLDINGS (GUERNSEY) LP, 

VX HOLDINGS, L.P., 

VIRGIN HOLDINGS LIMITED, 

CYRUS SELECT OPPORTUNITIES MASTER 

FUND, LTD., 
 CYR FUND,
L.P., 
 CRESCENT 1, L.P., 

CYRUS OPPORTUNITIES MASTER FUND II, LTD., 

CYRUS AVIATION INVESTOR, LLC, 

CYRUS AVIATION PARTNERS III, L.P., 

CYRUS AVIATION PARTNERS IIIA, L.P., 

CYRUS AVIATION PARTNERS IV, L.P., 

CM FINANCE INC, 
 CCP
INVESTMENTS I, L.P., and 
 CRS FUND, LTD. 

CYRUS AVIATION HOLDINGS, LLC, and 

VAI MBO INVESTORS LLC 

 TABLE OF CONTENTS 

 

									
	 	 	 	 	 	  	Page	 
			
	 1.
	 	 Definitions
	  	 	4	  
	 2.
	 	 Retained Proceeds
	  	 	11	  
	 3.
	 	 Treatment of Notes
	  	 	11	  
		 	 3.1
	 	 Cash Repayment of Repayment Notes
	  	 	11	  
		 	 3.2
	 	 Exchange of Premium Notes for Common Stock
	  	 	12	  
		 	 3.3
	 	 Exchange of Exchange Notes for the Virgin Group Post-IPO Note
	  	 	12	  
		 	 3.4
	 	 Exchange of Special Conversion Notes for Shares of Common Stock
	  	 	13	  
		 	 3.5
	 	 Exchange of Remaining Notes for Shares of Common Stock or Post-IPO Penny Warrants
	  	 	13	  
	 4.
	 	 Treatment of Warrants
	  	 	14	  
		 	 4.1
	 	 Exchange of Exchange Warrants for Shares of Common Stock or Post-IPO Penny Warrants
	  	 	14	  
		 	 4.2
	 	 Cancellation of Cancellation Warrants
	  	 	14	  
	 5.
	 	 Treatment of Capital Stock
	  	 	14	  
		 	 5.1
	 	 Exchange of Preferred Stock for Shares of Common Stock or Post-IPO Penny Warrants
	  	 	14	  
		 	 5.2
	 	 Automatic Conversion of Non-Class-A Common Stock
	  	 	14	  
	 6.
	 	 Allocation
	  	 	15	  
	 7.
	 	 Compliance with Federal Aviation Laws
	  	 	15	  
	 8.
	 	 Underwriters’ Overallotment in Initial Public Offering
	  	 	16	  
	 9.
	 	 Cooperation
	  	 	17	  
		 	 9.1
	 	 Amendments to Certificate of Incorporation
	  	 	17	  
		 	 9.2
	 	 Reimbursement Agreement
	  	 	17	  
		 	 9.3
	 	 Registration Rights Agreement
	  	 	17	  
		 	 9.4
	 	 Amended and Restated Virgin License
	  	 	17	  
		 	 9.5
	 	 Cyrus Recapitalization
	  	 	17	  
		 	 9.6
	 	 No Transfer of Securities
	  	 	17	  
		 	 9.7
	 	 Conflicts with Pre-IPO Transaction Documents
	  	 	17	  
		 	 9.8
	 	 Termination of Security Agreements and Intercreditor Agreement
	  	 	17	  
		 	 9.9
	 	 HSR Matters
	  	 	17	  
		 	 9.10
	 	 DOT Matters
	  	 	18	  
		 	 9.11
	 	 Voting and Cooperation
	  	 	18	  
	 10.
	 	 Representations and Warranties of the Company
	  	 	18	  
		 	 10.1
	 	 Organization; Powers
	  	 	18	  
		 	 10.2
	 	 Authorization; Enforceability
	  	 	18	  
		 	 10.3
	 	 Consents and Approvals; No Conflicts
	  	 	18	  
	 11.
	 	 Representations and Warranties of the Equityholders
	  	 	19	  
		 	 11.1
	 	 Authorization; Enforceability
	  	 	19	  
		 	 11.2
	 	 Compliance with Governmental Requirements and Other Instruments
	  	 	19	  
		 	 11.3
	 	 Acquisition for the Account of Each Equityholder
	  	 	19	  
		 	 11.4
	 	 Common Stock Not Registered
	  	 	19	  
		 	 11.5
	 	 Additional Acknowledgements
	  	 	20	  
		 	 11.6
	 	 Accredited Investor
	  	 	20	  
		 	 11.7
	 	 Economic Risk
	  	 	20	  
		 	 11.8
	 	 Rule 144
	  	 	20	  
		 	 11.9
	 	 Ownership of Securities
	  	 	20	  

  
 i 

									
	 12.
	 	 Miscellaneous
	  	 	21	  
		 	 12.1
	 	 Waivers and Amendments
	  	 	21	  
		 	 12.2
	 	 Notices
	  	 	21	  
		 	 12.3
	 	 Governing Law
	  	 	21	  
		 	 12.4
	 	 Waiver of Jury Trial, Punitive Damages, Etc.
	  	 	21	  
		 	 12.5
	 	 Entire Agreement
	  	 	22	  
		 	 12.6
	 	 Assignment; Successors and Assigns
	  	 	22	  
		 	 12.7
	 	 Counterparts
	  	 	22	  
		 	 12.8
	 	 Severability
	  	 	22	  
		 	 12.9
	 	 Specific Performance
	  	 	22	  
		 	 12.10
	 	 Further Assurances
	  	 	23	  
		 	 12.11
	 	 Restrictive Legends
	  	 	23	  
		 	 12.12
	 	 Withholding
	  	 	23	  
		 	 12.13
	 	 Effectiveness
	  	 	23	  
		 	 12.14
	 	 Interpretation
	  	 	24	  

 Schedules and Exhibits 
  

			
	Schedule A	  	ONPA Notes
	Schedule B	  	ANPA Notes
	Schedule C	  	TNPA Notes
	Schedule D	  	Fourth NPA Notes
	Schedule E	  	Fifth NPA Notes
	Schedule F	  	Related-Party Pre-IPO Warrants
		
	Exhibit A	  	Form of Virgin Group Post-IPO NPA
	Exhibit B	  	Form of Reimbursement Agreement
	Exhibit C	  	Form of Registration Rights Agreement
	Exhibit D	  	Form of Amended and Restated Virgin License

  
 ii 

 RECAPITALIZATION AGREEMENT 

THIS RECAPITALIZATION AGREEMENT (this “Agreement”) is dated as of
                 , 2014, and is being entered into by and among Virgin America Inc., a Delaware corporation (the “Company”); Virgin Management Limited,
a limited liability company organized under the laws of England and Wales (“VML”); VX Holdings, L.P., a Delaware limited partnership (“VXH”); VA Holdings (Guernsey) LP, a Guernsey limited partnership
(“VAHG”); Virgin Holdings Limited, a limited liability company organized under the laws of England and Wales (“VHL” and together with VXH, VML and VXH, the “Virgin Group”); Cyrus Select
Opportunities Master Fund, Ltd., a limited company based in the Cayman Islands (“CSOM”); CYR Fund, L.P., a Delaware limited partnership (“CYR”); Crescent 1, L.P., a Delaware limited partnership
(“Crescent”); Cyrus Opportunities Master Fund II, Ltd., a limited company based in the Cayman Islands (“COM”); Cyrus Aviation Investor, LLC (“Investor LLC”); Cyrus Aviation Partners III,
L.P., a Delaware limited partnership. (“CAP III”); Cyrus Aviation Partners IIIA, L.P., a Delaware limited partnership (“CAP IIIA”); Cyrus Aviation Partners IV, L.P., a Delaware limited partnership
(“CAP IV”); CCP Investments I, L.P., a Delaware limited partnership (“CCP”); CM Finance Inc, a Maryland corporation (“CMF”); CRS Fund, Ltd., a limited company based in the Cayman Islands
(“CRS,” and collectively with CSOM, CYR, Crescent, COM, Investor LLC, CAP III, CAP IIIA, CAP IV, CCP and CMF, the “Cyrus Parties”); Cyrus Aviation Holdings, LLC (“Cyrus Holdings”);
and VAI MBO Investors, LLC, a Delaware limited liability company (“MBO”). 
 RECITALS 

WHEREAS, the Company, VML and VAHG are parties to that certain Note Purchase Agreement, dated as of April 15, 2008, as amended by
Amendment No. 1 to the Note Purchase Agreement, dated as of July 6, 2008, as amended and restated as of November 3, 2008, as further amended by Amendment No. 1 to the Original Note Purchase Agreement, dated as of January 12,
2010, as further amended and restated as of December 9, 2011, and as further amended by that certain Amendment No. 1 to Second Amended and Restated Note Purchase Agreement, dated May 10, 2013 (the “Original NPA”)
pursuant to which the Company issued certain notes, which notes are currently held by the Equityholders reflected on Schedule A hereto (the “ONPA Notes”). 

WHEREAS, the Company, VML, VAHG, COM, CYR, Crescent and CSOM are party to that certain Additional Note Purchase Agreement, dated
November 3, 2008, as amended and restated as of January 12, 2010, and as amended to date, as further amended and restated as of December 9, 2011, and as further amended by that certain Amendment No. 1 to Second Amended and
Restated Additional Note Purchase Agreement, dated May 10, 2013 (the “Additional NPA”) pursuant to which the Company issued certain notes, which notes are currently held by the Equityholders reflected on Schedule B
hereto (the “ANPA Notes”). 
 WHEREAS, the Company, VML, VAHG, COM, CYR, Crescent and CSOM are party to that certain
Third Note Purchase Agreement, dated January 12, 2010, as amended and restated as of December 9, 2011, and as further amended by that certain Amendment No. 1 to the Amended and Restated Third Note Purchase Agreement, dated
May 10, 2013 (the “Third NPA”) pursuant to which the Company issued certain notes, which notes are currently held by the Equityholders reflected on Schedule C hereto (the “TNPA Notes”). 

 WHEREAS, the Company, VML, COM, CYR, Crescent, CSOM and CAP III are party to that certain
Fourth Note Purchase Agreement, dated December 9, 2011, as amended by that certain Amendment No. 1 to the Fourth Note Purchase Agreement, dated May 10, 2013 (the “Fourth NPA”) pursuant to which the Company issued
certain notes, which notes are currently held by the Equityholders reflected on Schedule D hereto (the “Fourth NPA Notes”). 

WHEREAS, on May 10, 2013, VML transferred all of the Fourth NPA Notes owned by it to CAP IIIA, CMF, COM and CCP. 

WHEREAS, the Company, VML, COM, CAP IV and CMF are party to that certain Fifth Note Purchase Agreement, dated May 10, 2013 (the
“Fifth NPA,” and collectively with the ONPA, the ANPA, the TNPA and the Fourth NPA, the “Note Purchase Agreements”) pursuant to which the Company issued certain notes, which notes are currently held by the
Equityholders reflected on Schedule E hereto (the “Fifth NPA Notes”). 
 WHEREAS, the obligations of the
Company under each of the Note Purchase Agreements are secured by substantially all of the assets of the Company pursuant to the terms of certain security agreements (collectively, the “Security Agreements”). 

WHEREAS, the Company, VML, VAHG, COM, CYR, Crescent, CSOM, CAP III, CRS, CAP IV and CMF are party to that certain Intercreditor
Agreement, dated December 9, 2011, as amended and restated as of May 10, 2013 (the “Intercreditor Agreement”), which details the relative rights of the various parties under the Note Purchase Agreements and the Security
Agreements with respect to the ONPA Notes, the ANPA Notes, the TNPA Notes, the Fourth NPA Notes and the Fifth NPA Notes (collectively, the “Notes”). 

WHEREAS, in connection with the Note Purchase Agreements and certain other transactions, the Company issued certain warrants to
purchase shares of Capital Stock (as defined below) of the Company, which are currently held (i) by the Virgin Group in the amounts and at the exercise prices set forth on Schedule F hereto (the “Virgin Group Pre-IPO
Warrants”); (ii) by the Cyrus Parties in the amounts and at the exercise prices set forth on Schedule F hereto (the “Cyrus Party Pre-IPO Warrants”); and (iii) by MBO in the amounts and at the exercise
prices set forth on Schedule F hereto (the “MBO Pre-IPO Warrants,” and collectively with the Virgin Group Pre-IPO Warrants and the Cyrus Party Pre-IPO Warrants, the “Related-Party Pre-IPO Warrants”). 

WHEREAS, the Company previously has issued to certain individuals not party to this Agreement certain other warrants to purchase shares
of Capital Stock of the Company (the “Third-Party Pre-IPO Warrants”), which shall expire if unexercised upon the consummation of the Initial Public Offering (as defined below). 

WHEREAS, immediately prior to the VAI Distributions (as defined below) and before giving effect to the Reverse Split (as defined
below), (i) VAI Partners LLC, a Delaware limited 

  
 2 

 
liability company (“VAI”), held an aggregate of 1,874,474 shares of Class A Common Stock, 220,000 shares of Class A-1 Common Stock and 8,377,895 shares of Preferred
Stock (collectively, the “VAI Securities”) and (ii) VAI Management, LLC (“VAI Manager”) held certain Related-Party Pre-IPO Warrants. 

WHEREAS, prior to the Recapitalization (as defined below), (i) VAI distributed all of the VAI Securities to Investor LLC, VX
Employee Holdings, LLC, MBO and VAI Manager, and (ii) VAI Manager distributed all of the Related-Party Pre-IPO Warrants held by it and all of the VAI Securities that it received from VAI to Investor LLC and MBO (the “VAI
Distributions”). 
 WHEREAS, following VAI Distributions and prior to the consummation of the Recapitalization (as defined
below), the Company filed an amendment to its amended and restated certificate of incorporation pursuant to which (i) each 7.5489352 (the “Reverse Split Amount”) outstanding shares of each class of Capital Stock were
automatically combined and converted into one share of such class (the “Reverse Split”) and (ii) after giving effect to the Reverse Split, each outstanding share of the Company’s Class A Common Stock was automatically
converted (without any further action by the holders thereof) into one share of Common Stock (as defined below). In connection with the Reverse Split, the Company also paid in cash the fair value of each fractional share resulting from the Reverse
Split. 
 WHEREAS, notwithstanding anything to the contrary in the Note Purchase Agreements, the Security Agreements, the
Intercreditor Agreement or the Related-Party Pre-IPO Warrants (collectively, the “Pre-IPO Transaction Documents”), in connection with and in order to facilitate the consummation by the Company of the sale of shares of its Capital
Stock made effective pursuant to the Securities Act of 1933, as amended (the “Securities Act”) pursuant to a firm underwritten public offering registered on a registration statement on Form S-1 (or any successor thereto) (the
“Initial Public Offering”), and subject to any filings required by the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), and the related expiration or early termination of any
required waiting period thereunder, the parties hereto wish to provide for the following (collectively, the “Recapitalization”): (i) the Company shall retain the Retained Proceeds (as defined below) for purposes of liquidity;
(ii) Restricted Cash Amount (as defined below) and an amount of Net Proceeds (as defined below) from the Initial Public Offering equal to the Recapitalization Proceeds (as defined below) shall be used by the Company to repay accrued and unpaid
(by way of PIK or otherwise) interest on and the aggregate principal amount of the Repayment Notes (as defined below); (iii) accrued and unpaid (by way of PIK or otherwise) interest on and the aggregate principal amount of all Premium Notes (as
defined below) shall be exchanged for either shares of Common Stock at a price per share equal to the Premium Conversion Price (as defined below); (iv) the Exchange Notes (as defined below) shall be exchanged for the Virgin Group Post-IPO Note
(as defined below); (v) accrued and unpaid (by way of PIK or otherwise) interest on and the aggregate principal amount of all Special Conversion Notes (as defined below) shall be exchanged for shares of Common Stock at a price per share equal
to the Offering Price (as defined below); (vi) accrued and unpaid (by way of PIK or otherwise) interest on and the aggregate principal amount of the Remaining Notes (as defined below) shall be exchanged for shares of Common Stock at a price per
share equal to the Offering Price or certain Post-IPO Penny Warrants (as defined below) as provided for herein; (vii) each Exchange Warrant (as defined below) shall be exchanged for either shares of Common Stock at a price per share equal to
the Offering Price or Post-IPO Penny Warrants as provided for herein; 

  
 3 

 
(viii) each Cancellation Warrant (as defined below) shall be cancelled in full; (ix) all outstanding shares of Preferred Stock (as defined below) shall be exchanged for either shares of
Common Stock at a price per share equal to the Offering Price or Post-IPO Penny Warrants as provided for herein; and (x) all outstanding shares of Non-Class-A Common Stock held by parties to this Agreement shall be automatically converted into
shares of Common Stock in accordance with the rights and privileges of such shares. 
 WHEREAS, immediately following the
transactions contemplated by Sections 3.2, 3.3, 3.4, 3.5, 4 and 5 below and on the date of the Pricing (as defined below), each of the Cyrus Parties, other than CMF, will effect a transaction by which the
securities of the Company will be held by Cyrus Holdings, with the effect that no securities held by Cyrus Holdings will constitute Alien-Owned Shares (the “Cyrus Recapitalization”). 

WHEREAS, in connection with and in order to facilitate the Initial Public Offering, and in order to give effect to the
Recapitalization, the Company and each Equityholder hereby enter into this Agreement on the date hereof, which shall be the date on which the Board of Directors of the Company or any pricing committee thereof sets the price per share of Common Stock
for the Initial Public Offering (the “Pricing”). 
 AGREEMENT 

NOW, THEREFORE, in consideration of the mutual promises, representations, warranties, covenants, conditions and agreements contained
herein, and other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound by the terms hereof, hereby as follows: 

1. Definitions. As used in this Agreement, each capitalized term has the meaning ascribed to it in this Section 1:

 “Additional NPA” shall have the meaning ascribed to such term in the recitals hereto. 

“Agreement” shall have the meaning ascribed to such term in the preamble hereto, as amended from time to time. 

“Alien-Owned” shall mean owned of record or owned beneficially, or otherwise controlled, by any Person or Persons who is/are
not United States Citizens. 
 “Amended and Restated Virgin License” shall have the meaning ascribed to such term in
Section 9.2. 
 “ANPA Notes” shall have the meaning ascribed to such term in the recitals hereto. 

“Business Day” shall mean any day that is not a Saturday, Sunday or other day on which commercial banks in New York, New York
or London, England are authorized or required by law to remain closed. 

  
 4 

 “Business” shall mean the business of the Company as currently conducted. 

“CAP III” shall have the meaning ascribed to such term in the preamble hereto. 

“CAP IIIA” shall have the meaning ascribed to such term in the preamble hereto. 

“CAP IV” shall have the meaning ascribed to such term in the preamble hereto. 

“Cancellation Warrants” shall have the meaning ascribed to such term in Section 4.2. 

“Capital Stock” shall mean the any capital stock of the Company. 

“CCP” shall have the meaning ascribed to such term in the preamble hereto. 

“CMF” shall have the meaning ascribed to such term in the preamble hereto. 

“COM” shall have the meaning ascribed to such term in the preamble hereto. 

“Common Stock” shall mean the Non-Voting Common Stock and Voting Common Stock of the Company, or any successor shares into
which such Common Stock is exchanged or reclassified. 
 “Company” shall have the meaning ascribed to such term in the
preamble hereto. 
 “Crescent” shall have the meaning ascribed to such term in the preamble hereto. 

“CRS” shall have the meaning ascribed to such term in the preamble hereto. 

“CSOM” shall have the meaning ascribed to such term in the preamble hereto. 

“CYR” shall have the meaning ascribed to such term in the preamble hereto. 

“Cyrus Holdings” shall have the meaning ascribed to such term in the preamble hereto; 

“Cyrus Parties” shall have the meaning ascribed to such term in the preamble hereto. 

“Cyrus Party Pre-IPO Warrants” shall have the meaning ascribed to such term in the recitals hereto. 

“Cyrus Recapitalization” shall have the meaning ascribed to such term in the recitals hereto. 

“DOT” shall mean the U.S. Department of Transportation. 

“Employee LLC Proceeds” shall mean cash proceeds from the Initial Public Offering received by VX Employee Holdings, LLC, net
of all underwriter commissions, which proceeds will be remitted to the Company for distribution to certain of the Company’s employees. 

  
 5 

 “Equityholders” shall mean each of the Cyrus Parties, Cyrus Holdings, each party
in the Virgin Group and MBO. 
 “Estimated Transaction Expenses Amount” shall mean $4,214,095. 

“Exchange Notes” shall have the meaning ascribed to such term in Section 3.3(a). 

“Exchange Warrants” shall mean all Class A Warrants, Class C-2 Warrants, Class C-4 Warrants, Class C-11 Warrants, Class
C-12 Warrants, Class C-14 Warrants and Class C-15 Warrants of the Company outstanding as of the Pricing, as reflected on Schedule F. 

“Federal Aviation Laws” shall mean the federal aviation laws codified in title 49 of the United States Code. 

“Fifth NPA” shall have the meaning ascribed to such term in the recitals hereto. 

“Fifth NPA Notes” shall have the meaning ascribed to such term in the recitals hereto. 

“Fourth NPA” shall have the meaning ascribed to such term in the recitals hereto. 

“Fourth NPA Notes” shall have the meaning ascribed to such term in the recitals hereto. 

“Governmental Authority” shall mean the government of the United States of America, any other nation or any political
subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or
pertaining to government. 
 “Governmental Requirement” shall mean any law, statute, code, ordinance, order, determination,
rule, regulation, judgment, decree, injunction, franchise, permit, certificate, license, authorization or other directive or requirement (whether or not having the force of law), including, without limitation, environmental laws, energy regulations
and occupational, safety and health standards or controls, of any Governmental Authority. 
 “Holdback Letter of Credit”
shall mean any standby letter of credit issued by Barclays Bank plc or one of its affiliates at the request of Virgin Group, and upon the terms and conditions agreed upon between the Company, Virgin Group and any LC Beneficiary, to be issued in
favor of any LC Beneficiary for the purpose of satisfying the Company’s cash holdback requirements for the Company’s air traffic liability set forth in agreements between the Company and such LC Beneficiary. 

“HSR Act” shall have the meaning ascribed to such term in the recitals hereto. 

  
 6 

 “Initial Public Offering” shall have the meaning ascribed to such term in the
recitals hereto. 
 “Intercreditor Agreement” shall have the meaning ascribed to such term in the recitals hereto. 

“Investor LLC” shall have the meaning ascribed to such term in the preamble hereto; 

“LC Beneficiary” shall mean each of U.S. Bank, National Association and America Express Travel Related Services Company, Inc.

 “LC Transaction” shall mean the establishment of one or more Holdback Letters of Credit for the purpose of enabling the
LC Beneficiaries to release an amount of cash equal to the Restricted Cash Amount from the holdback restrictions under the Company’s agreements with such LC Beneficiaries. 

“Lessor Obligations” shall mean an amount equal to $        , which represents
certain obligations owed by the Company to certain of its aircraft lessors in connection with previously negotiated reductions in aircraft rent expense. 

“Lien” shall mean, with respect to any asset, (a) any mortgage, deed of trust, lien, pledge, hypothecation, security
agreement, encumbrance, charge, option or security interest in, on or of such asset and (b) the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement (or any financing lease having
substantially the same economic effect as any of the foregoing) relating to such asset. 
 “Material Adverse Effect” shall
mean any event, change or development, or combination of events, changes or developments, individually or in the aggregate, that has or would reasonably be expected to have a material adverse effect on the Business, results of operations, assets,
liabilities, operations, property, prospects or financial condition of the Company. 
 “MBO” shall have the meaning
ascribed to such term in the preamble hereto. 
 “MBO Pre-IPO Warrants” shall have the meaning ascribed to such term in the
recitals hereto. 
 “Net Proceeds” shall mean cash proceeds received by the Company from the shares sold by the Company in
the Initial Public Offering (but not including any proceeds from the sale of the Withholding Shares), net of all underwriter commissions, the Estimated Transaction Expense Amount and the Secondary Sale Expenses. For the avoidance of any doubt, Net
Proceeds shall not include any Employee LLC Proceeds. 
 “Non-Class-A Common Stock” shall mean (a) the Company’s
Class A-1 Common Stock, par value $0.01 per share; (b) the Company’s Class B Common Stock, par value $0.01 per share; (c) the Company’s Class C Common Stock, par value $0.01 per share; and (d) the Company’s Class G
Common Stock, par value $0.01 per share, in each case, outstanding prior to the Pricing. 

  
 7 

 “Non-Voting Common Stock” shall mean the non-voting common stock of the Company,
par value $0.01 per share, or any successor shares into which such Common Stock is exchanged or reclassified. 
 “Note Purchase
Agreements” shall have the meaning ascribed to such term in the recitals hereto. 
 “Notes” shall have the meaning
ascribed to such term in the recitals hereto. 
 “Offering Price” shall mean a price per share equal to the public offering
price per share in the Initial Public Offering. 
 “ONPA Notes” shall have the meaning ascribed to such term in the
recitals hereto. 
 “Original NPA” shall have the meaning ascribed to such term in the recitals hereto. 

“Overallotment Shares” shall mean have the meaning ascribed to such term in Section 8. 

“Person” shall mean any natural person, corporation, limited liability company, trust, joint venture, association, company,
partnership, Governmental Authority or other entity. 
 “Post-IPO Penny Warrants” shall mean warrants to purchase shares of
Common Stock at an exercise price of $0.01 per share with a term equal to thirty (30) years from the date of the Pricing. 

“Pricing” shall have the meaning ascribed to such term in the recitals hereto. 

“Preferred Stock” shall mean the Company’s Convertible Preferred Stock, par value $0.01 per share, outstanding prior to
the Pricing. 
 “Preferred Stock Value” shall mean the product of (i) the total number of outstanding shares of
Preferred Stock and (ii) the Offering Price. 
 “Premium Conversion Price” shall mean a price per share equal to the
Offering Price divided by 1.17. 
 “Premium Notes” shall have the meaning ascribed to such term in
Section 3.2(a). 
 “Recapitalization” shall have the meaning ascribed to such term in the recitals hereto. 

“Recapitalization Proceeds” shall mean have the meaning ascribed to such term in Section 3.1(a). 

  
 8 

 “Reimbursement Agreement” shall mean have the meaning ascribed to such term in
Section 9.2. 
 “Related-Party Pre-IPO Warrants” shall mean the Virgin Group Pre-IPO Warrants, the Cyrus Party
Pre-IPO Warrants and the MBO Pre-IPO Warrants. 
 “Remaining Notes” shall have the meaning ascribed to such term in
Section 3.5(a). 
 “Repayment Notes” shall have the meaning ascribed to such term in
Section 3.1(a). 
 “Requisite Equityholders” shall mean each of VXH and Cyrus Holdings. 

“Restricted Cash Amount” shall have the meaning ascribed to such term in Section 3.1(a). 

“Retained Proceeds” shall have the meaning ascribed to such term in Section 2. 

“Reverse Split” shall have the meaning ascribed to such term in the recitals hereto. 

“Reverse Split Amount” shall have the meaning ascribed to such term in the recitals hereto. 

“Securities Act” shall have the meaning ascribed to such term in the recitals hereto. 

“Secondary Sale Expenses” shall mean all underwriter commissions to be borne by Company in connection with the sale by Cyrus
Holdings and the Virgin Group of certain shares of Common Stock to PAR Investment Partners, L.P. after the Recapitalization, pursuant to the Securities Purchase Agreement dated on or about the date hereof, and any amounts to be paid thereunder by
the Company to Cyrus Holdings and the Virgin Group. 
 “Security Agreements” shall have the meaning ascribed to such term
in the recitals hereto. 
 “Special Conversion Amount” shall mean $50,000,000 divided by 0.96. 

“Special Conversion Notes” shall mean (a) Fourth NPA Notes held by the Cyrus Parties in an aggregate amount equal to one
half of the Special Conversion Amount, on a pro rata basis determined by the principal amount of the Fourth NPA Notes held by each such entity; and (b) Fifth NPA Notes held by the Virgin Group in an aggregate amount equal to one half of the
Special Conversion Amount, on a pro rata basis determined by the principal amount of the Fifth NPA Notes held by each such entity. 

“Third-Party Pre-IPO Warrants” shall have the meaning ascribed to such term in the recitals hereto. 

  
 9 

 “Third NPA” shall have the meaning ascribed to such term in the recitals hereto.

 “TNPA Notes” shall have the meaning ascribed to such term in the recitals hereto. 

“UCC” means the Uniform Commercial Code as adopted in the States of New York and Florida, as from time to time amended. 

“United States Citizen” shall mean a “citizen of the United States,” as defined in 49 U.S.C.
Section 40102(a)(15), as in effect on the date in question, or any successor statute or regulation, as interpreted by the DOT in applicable precedent. 

“VAHG” shall have the meaning ascribed to such term in the preamble hereto. 

“VAI” shall have the meaning ascribed to such term in the recitals hereto. 

“VAI Distributions” shall have the meaning ascribed to such term in the recitals hereto. 

“VAI Manager” shall have the meaning ascribed to such term in the recitals hereto. 

“VAI Securities” shall have the meaning ascribed to such term in the recitals hereto. 

“VHL” shall have the meaning ascribed to such term in the preamble hereto. 

“Virgin Group” shall have the meaning ascribed to such term in the preamble hereto. 

“Virgin Group Post-IPO Note” shall mean the new note to be issued by the Company pursuant to the Virgin Group Post-IPO NPA,
in the form attached as Exhibit A to the Virgin Group Post-IPO NPA. 
 “Virgin Group Post-IPO NPA” shall mean the Note
Purchase Agreement to be entered into between the Company and VML in the form attached hereto as Exhibit A. 
 “Virgin Group
Pre-IPO Warrants” shall have the meaning ascribed to such term in the recitals hereto. 
 “VML” shall have the
meaning ascribed to such term in the preamble hereto. 
 “Voting Common Stock” shall mean the voting common stock of the
Company, par value $0.01 per share, or any successor shares into which such Common Stock is exchanged or reclassified. 

“VXH” shall have the meaning ascribed to such term in the preamble hereto. 

“Warrant Value” shall mean, (a) with respect to any Exchange Warrant other than Class C-11 Warrants and Class C-12
Warrants, the product of (i) the difference of the Offering 

  
 10 

 
Price minus the exercise price per Exchange Warrant Share of such Exchange Warrant (after giving effect to any adjustments arising from the Reverse Split), as adjusted for any stock splits or
recapitalizations pursuant to the terms thereof, multiplied by (ii) the number of Exchange Warrant Shares issuable upon exercise of such Exchange Warrant (after giving effect to any adjustments arising from the Reverse Split) and (b) with
respect to any Class C-11 Warrants or Class C-12 Warrants, the product of (i) the difference of the Offering Price minus the product obtained by multiplying $2.50 by the Reverse Split Amount, as adjusted for any stock splits or
recapitalizations pursuant to the terms thereof, multiplied by (ii) the number of Exchange Warrant Shares issuable upon exercise of such Class C-11 Warrants or Class C-12 Warrants (after giving effect to any adjustments arising from the Reverse
Split). 
 “Withholding Shares” shall mean 96,847 of the shares of Common Stock sold by the Company in the Initial Public
Offering. 
 2. Retained Proceeds. Notwithstanding any terms of this Agreement to the contrary, of the Net Proceeds, the
Company shall retain (i) the amount required, as determined by the Board of Directors of the Company immediately prior to the consummation of the Recapitalization, such that the Company’s cash and cash equivalents immediately following the
Initial Public Offering equal approximately twenty-seven percent (27%) of the Company’s total revenue for the preceding twelve months and (ii) an amount equal to the Lessor Obligations, which shall be in addition to the amounts
described in clause (i) (together, the “Retained Proceeds”). 
 3. Treatment of Notes. 

3.1 Cash Repayment of Repayment Notes. 

(a) The Company shall use the sum of (x) $100,000,000 (the “Restricted Cash Amount”) and (y) the balance of the
Net Proceeds after deducting the Retained Proceeds (the “Recapitalization Proceeds”) to pay the holders of the following Notes (the “Repayment Notes”), as follows: 

(i) At or prior to the closing of the Initial Public Offering, the Restricted Cash Amount shall be used to repay the accrued and unpaid (by
way of PIK or otherwise) interest and then outstanding principal amounts on certain of the ONPA Notes, ANPA Notes and/or TNPA Notes held by the Virgin Group and identified by the Virgin Group to the Company in writing no later than two business days
prior to the Pricing; 
 (ii) Immediately upon the closing of the Initial Public Offering, fifty percent (50%) of the Recapitalization
Proceeds shall be used to repay the accrued and unpaid (by way of PIK or otherwise) interest and then outstanding principal amounts on the Fourth NPA Notes, other than the Special Conversion Notes, held by the Cyrus Parties on a pro rata basis
determined by the principal amount of such Notes held by each such entity; 
 (iii) Immediately upon the closing of the Initial Public
Offering, fifty percent (50%) of the Recapitalization Proceeds, or such lesser amount as may be required to repay the accrued and unpaid (by way of PIK or otherwise) interest and then outstanding principal amounts on the Fifth NPA Notes held by
the Virgin Group, other than the Special 

  
 11 

 
Conversion Notes, shall be used to repay the accrued and unpaid (by way of PIK or otherwise) interest and then outstanding principal amounts on the Fifth NPA Notes, other than the Special
Conversion Notes, held by the Virgin Group on a pro rata basis determined by the principal amount of such Notes held by each such entity; 

(iv) Immediately upon the closing of the Initial Public Offering, any remaining Recapitalization Proceeds after giving effect to Sections
3.1(a)(ii)-(iii) above, shall be used to repay accrued and unpaid (by way of PIK or otherwise) interest and principal amounts on certain of the ONPA Notes, ANPA Notes and/or TNPA Notes held by the Virgin Group and identified by the Virgin
Group to the Company in writing no later than two business days prior to the Pricing. 
 (b) Each holder of a Repayment Note expressly
consents to the repayment of the Repayment Notes as set forth in this Section 3.1. 
 3.2 Exchange of Premium Notes for
Common Stock. 
 (a) Substantially contemporaneously with the Pricing, any accrued and unpaid (by way of PIK or otherwise) interest
and then outstanding principal amounts of any Fourth NPA Notes and Fifth NPA Notes other than the Repayment Notes and the Special Conversion Notes (the “Premium Notes”) shall be automatically exchanged and, effective upon such
exchange, cancelled, and each holder of a Premium Note forgives and extinguishes all indebtedness represented by such Premium Note, including any accrued and unpaid (by way of PIK or otherwise) interest thereon, and waives receipt of all amounts due
and owing on the Premium Note, in exchange for a number of shares of Voting Common Stock (rounded down to the nearest whole share) equal to the quotient of (i) all accrued and unpaid (by way of PIK or otherwise) interest and then outstanding
principal amounts of the Premium Notes held by a particular holder of Premium Notes divided by (ii) Premium Conversion Price. 
 (b)
Each holder of a Premium Note exchanged pursuant to this Section 3.2 agrees to the cancellation and termination of all rights relating to the Premium Note upon the exchange of the Premium Note, whether or not the Premium Note has been
surrendered. Notwithstanding the foregoing, each holder of a Premium Note agrees to surrender, at or before the Pricing, such Premium Note to the Company for exchange and cancellation in connection herewith or to execute and deliver to the Company
an affidavit of loss and indemnity reasonably satisfactory to the Company. 
 3.3 Exchange of Exchange Notes for the Virgin Group
Post-IPO Note. 
 (a) Substantially contemporaneously with the Pricing an outstanding principal amount of up to $50,000,000 of the
TNPA Notes held by the VML and not paid pursuant to Section 3.1 (the “Exchange Notes”), shall be exchanged for the Virgin Group Post-IPO Note of identical principal amount. 

(b) Each holder of an Exchange Note exchanged pursuant to this Section 3.3 agrees to the cancellation and termination of all
rights relating to the Exchange Note upon the exchange of the Exchange Note, whether or not the Exchange Note has been surrendered. Notwithstanding the foregoing, each holder of an Exchange Note agrees to

  
 12 

 
surrender, at or before the Pricing, such Exchange Note to the Company for exchange and cancellation in connection herewith or to execute and deliver to the Company an affidavit of loss and
indemnity reasonably satisfactory to the Company. 
 3.4 Exchange of Special Conversion Notes for Shares of Common Stock. 

(a) Substantially contemporaneously with the Pricing, the accrued and unpaid (by way of PIK or otherwise) interest and then outstanding
principal amounts of the Special Conversion Notes shall be automatically exchanged and, effective upon such exchange, cancelled, and each holder of a Special Conversion Note forgives and extinguishes all indebtedness represented by such Special
Conversion Note, including any accrued and unpaid (by way of PIK or otherwise) interest thereon, and waives receipt of all amounts due and owing on the Special Conversion Note, in exchange for a number of shares of Voting Common Stock (rounded down
to the nearest whole share) equal to the quotient of (i) the accrued and unpaid (by way of PIK or otherwise) interest and then outstanding principal amounts of the Special Conversion Notes held by a particular holder of Special Conversion Notes
divided by (ii) the Offering Price. 
 (b) Each holder of a Special Conversion Note exchanged pursuant to this
Section 3.4 agrees to the cancellation and termination of all rights relating to the Special Conversion Note upon the exchange of the Special Conversion Note, whether or not the Special Conversion Note has been surrendered.
Notwithstanding the foregoing, each holder of a Special Conversion Note agrees to surrender, at or before the Pricing, such Special Conversion Note to the Company for exchange and cancellation in connection herewith or to execute and deliver to the
Company an affidavit of loss and indemnity reasonably satisfactory to the Company. 
 3.5 Exchange of Remaining Notes for Shares of
Common Stock or Post-IPO Penny Warrants. 
 (a) Substantially contemporaneously with the Pricing, any accrued and unpaid (by way of
PIK or otherwise) interest and then outstanding principal amounts of all Notes other than the Repayment Notes, the Premium Notes, the Exchange Notes and the Special Conversion Notes (collectively, the “Remaining Notes”) shall be
automatically exchanged and, effective upon such exchange, cancelled, and each holder of a Remaining Note forgives and extinguishes all indebtedness represented by such Remaining Note, including any accrued and unpaid (by way of PIK or otherwise)
interest thereon, and waives receipt of all amounts due and owing on the Remaining Note, in exchange for either (X) a number of shares of Voting Common Stock or Non-Voting Common Stock (each rounded down to the nearest whole share) equal to the
quotient of (i) any accrued and unpaid (by way of PIK or otherwise) interest and then outstanding principal amounts of the Remaining Notes held by a particular holder of Remaining Notes divided by (ii) the Offering Price or
(Y) Post-IPO Penny Warrants exercisable for that number of shares of Common Stock (rounded down to the nearest whole share) equal to the quotient of (i) any accrued and unpaid (by way of PIK or otherwise) interest and then outstanding
principal amounts of the Remaining Notes held by a particular holder of Remaining Notes divided by (ii) the difference of the Offering Price minus $0.01, or a combination thereof, in each case as further detailed in Section 7. 

  
 13 

 (b) Each holder of a Remaining Note exchanged pursuant to this Section 3.5 agrees to
the cancellation and termination of all rights relating to the Remaining Note upon the exchange of the Remaining Note, whether or not the Remaining Note has been surrendered. Notwithstanding the foregoing, each holder of a Remaining Note agrees to
surrender, at or before the Pricing, such Remaining Note to the Company for exchange and cancellation in connection herewith or to execute and deliver to the Company an affidavit of loss and indemnity reasonably satisfactory to the Company. 

4. Treatment of Warrants. 

4.1 Exchange of Exchange Warrants for Shares of Common Stock or Post-IPO Penny Warrants. Substantially contemporaneously with
the Pricing, each Exchange Warrant shall be automatically cancelled and exchanged for either (X) a number of shares of Voting Common Stock or Non-Voting Common Stock (each rounded down to the nearest whole share) equal to the quotient of
(i) the Warrant Value of such Exchange Warrant divided by (ii) the Offering Price or (Y) Post-IPO Penny Warrants exercisable for that number of shares of Common Stock (rounded down to the nearest whole share) equal to the quotient of
(i) the Warrant Value divided by (ii) the difference of the Offering Price minus $0.01, or a combination thereof, in each case as further detailed in Section 7. Each Equityholder that holds an Exchange Warrant as of the Pricing
agrees to surrender, at or before the Pricing, such Exchange Warrant to the Company for exchange and cancellation in connection herewith or to execute and deliver to the Company an affidavit of loss and indemnity reasonably satisfactory to the
Company. 
 4.2 Cancellation of Cancellation Warrants. Substantially contemporaneously with the Pricing, each Related-Party
Pre-IPO Warrant other than the Exchange Warrants (collectively, the “Cancellation Warrants”) shall be automatically cancelled in full. Each Equityholder that holds a Cancellation Warrant as of the Pricing agrees to surrender, at or
before the Pricing, such Cancellation Warrant to the Company for cancellation in connection herewith or to execute and deliver to the Company an affidavit of loss and indemnity reasonably satisfactory to the Company. 

5. Treatment of Capital Stock. 

5.1 Exchange of Preferred Stock for Shares of Common Stock or Post-IPO Penny Warrants. Substantially contemporaneously with the
Pricing, the total number of outstanding shares of Preferred Stock held by each Equityholder shall be automatically cancelled and exchanged for either (X) an equivalent number of shares of Voting Common Stock or Non-Voting Common Stock or
(Y) Post-IPO Penny Warrants exercisable for that number of shares of Common Stock (rounded down to the nearest whole share) equal to the quotient of (i) the Preferred Stock Value divided by (ii) the difference of the Offering Price
minus $0.01, or a combination thereof, in each case as further detailed in Section 7. Each Equityholder that holds shares of Preferred Stock as of the Pricing agrees to surrender, at or before the Pricing, the original stock certificates
representing such shares or to execute and deliver to the Company an affidavit of loss and indemnity reasonably satisfactory to the Company. 

5.2 Automatic Conversion of Non-Class-A Common Stock. Substantially contemporaneously with the Pricing, all outstanding shares
of Non-Class-A Common Stock held 

  
 14 

 
by any Equityholder shall be automatically converted (without any further action by the holders thereof) into shares of Common Stock in accordance with the rights and privileges of such shares.
Each Equityholder that holds shares of Non-Class-A Common Stock as of the Pricing agrees to surrender, at or before the Pricing, the original stock certificates representing such shares or to execute and deliver to the Company an affidavit of loss
and indemnity reasonably satisfactory to the Company. 
 6. Allocation. For the avoidance of doubt, no later than two days
prior to the Pricing, the Company will deliver to the Equityholders in electronic format a model for the calculation of all securities issuable and payments to be made pursuant to the terms of this Agreement in relation to the Notes, the
Related-Party Pre-IPO Warrants, the Preferred Stock and the Non-Class-A Common Stock, after giving effect to the provisions of Section 7, and the parties hereto shall take all reasonable steps necessary to ensure that such model reflects
the provisions of this Agreement. Notwithstanding the foregoing and provided that the Company remains at all times a United States Citizen under the Federal Aviation Laws, upon written instruction delivered to the Company prior to the Pricing: 

(a) the Virgin Group shall have the right to specify among the Virgin Group entities the allocation of (i) the amount of the Restricted
Cash Amount and the Recapitalization Proceeds payable to the Virgin Group pursuant to Section 3.1; (ii) the shares of Voting Common Stock or Non-Voting Common Stock or Post-IPO Penny Warrants issuable to the Virgin Group pursuant to
Section 3.2, Section 3.4, Section 3.5, Section 4.1 and Section 5.1, subject to the terms of Section 7; and (iii) the amount of the Exchange Notes to be exchanged and the
Virgin Group Post-IPO Note to be issued to the Virgin Group pursuant to Section 3.3; and 
 (b) the Cyrus Parties shall have
the right to specify among the such entities the allocation of (i) the amount of the Restricted Cash Amount and the Recapitalization Proceeds payable to the Cyrus Parties pursuant to Section 3.1; and (ii) the shares of Voting
Common Stock, Non-Voting Common Stock or Post-IPO Penny Warrants issuable to the Cyrus Parties pursuant to Section 3.2, Section 3.4, Section 3.5, Section 4.1 and Section 5.1, subject to the
terms of Section 7. 
 7. Compliance with Federal Aviation Laws. 

(a) So that the Company can ensure that it remains at all times a United States Citizen under the Federal Aviation Laws, wherever
Section 3.2, Section 3.4, Section 3.5, Section 4.1 and Section 5.1 of this Agreement provide for the issuance of either Voting Common Stock, Non-Voting Common Stock or Post-IPO Penny
Warrants, or a combination thereof, the securities so provided for shall be issued in the following manner: 
 (i) To the extent such
securities when issued would not constitute Alien-Owned shares, such securities shall be issued as shares of Voting Common Stock; 
 (ii)
To the extent that (i) shares of Voting Common Stock when issued would constitute Alien-Owned shares; and (ii) the issuance of such Voting Common 

  
 15 

 
Stock would not cause the aggregate amount of all outstanding Alien-Owned voting stock of the Company to represent more than nineteen percent (19%) of the total outstanding voting
stock of the Company, such securities shall be issued as shares of Voting Common Stock; 
 (iii) To the extent that (i) shares of
Voting Common Stock when issued would constitute Alien-Owned shares; (ii) the issuance of Voting Common Stock would cause the aggregate amount of all outstanding Alien-Owned voting stock of the Company to represent more than nineteen percent
(19%) of the total outstanding voting stock of the Company; and (iii) the issuance of Non-Voting Common Stock would not cause the aggregate amount of all outstanding Alien-Owned stock of the Company to represent more than forty-four
percent (44%) of the total outstanding stock of the Company, such securities shall be issued as shares of Non-Voting Common Stock; and 

(iv) To the extent that (i) shares of Voting Common Stock when issued would constitute Alien-Owned shares; (ii) the issuance of
Voting Common Stock would cause the aggregate amount of all outstanding Alien-Owned voting stock of the Company to represent more than nineteen percent (19%) of the total outstanding voting stock of the Company; and (iii) the issuance of
Non-Voting Common Stock would cause the aggregate amount of all outstanding Alien-Owned stock of the Company to represent more than forty-four percent (44%) of the total outstanding stock of the Company, such securities shall be issued as
Post-IPO Penny Warrants. 
 (b) Following the Initial Public Offering, the rights of the Voting Common Stock and Non-Voting Common Stock
shall be set forth in the Company’s amended and restated certificate of incorporation and bylaws, each as in effect immediately following the closing of the Initial Public Offering and as amended from time to time. Pursuant to such governing
documents, the Company shall have the power to, and shall, convert any shares of Voting Common Stock, including any shares of Voting Common Stock issued pursuant to Section 3.2, Section 3.4, Section 3.5,
Section 4.1, Section 5.1 and Section 5.2, into Non-Voting Common Stock to reduce the voting interest in the Company represented by Alien-Owned shares as set forth in further detail therein. 

8. Underwriters’ Overallotment in Initial Public Offering. Subject to compliance with any applicable legal requirements,
each of the parties to this Agreement hereby agrees that, the underwriting agreement to be entered into in connection with the Initial Public Offering shall provide that, if the underwriters of the Initial Public Offering determine to exercise their
right to purchase additional shares of Common Stock (“Overallotment Shares”) pursuant to an overallotment option between the Company and such underwriters, then fifty percent (50%) of the Overallotment Shares shall consist of
Common Stock held by the Virgin Group and fifty percent (50%) of the Overallotment Shares shall consist of Common Stock held by Cyrus Holdings and CMF, and each of the Virgin Group, Cyrus Holdings and CMF, respectively, shall be entitled to
retain the proceeds (net of underwriter discounts and commissions) from the sale of such shares. 

  
 16 

 9. Cooperation. 

9.1 Amendments to Certificate of Incorporation. The parties hereto shall take all reasonable steps necessary to amend, modify or
waive the provisions of the Company’s certificate of incorporation, to the extent necessary, to provide for the transactions contemplated by this Agreement. 

9.2 Reimbursement Agreement. The Company and the Virgin Group shall take all reasonable steps necessary to effect the LC
Transaction. Immediately upon the Closing of the Initial Public Offering, the Company and VHL shall execute and deliver that certain Letter of Credit Reimbursement Agreement in the form attached hereto as Exhibit B (the “Reimbursement
Agreement”). 
 9.3 Registration Rights Agreement. That certain Registration Rights Agreement in the form attached
hereto as Exhibit C (the “Registration Rights Agreement”) shall have been executed and delivered by each of the Company, Cyrus Holdings, CMF and each entity in the Virgin Group prior to the consummation of the
transactions contemplated by Section 3, Section 4 and Section 5. 
 9.4 Amended and Restated
Virgin License. That certain Amended and Restated Virgin America Trade Mark License in the form attached hereto as Exhibit D (the “Amended and Restated Virgin License”) shall have been executed and delivered by each
of the Company, Virgin Aviation TM Limited and Virgin Enterprises Limited prior to the consummation of the transactions contemplated by Section 3, Section 4 and Section 5. 

9.5 Cyrus Recapitalization. Each of the Cyrus Parties, other than CMF, and Cyrus Holdings hereby covenants and agrees that it
shall take all necessary actions to effect the Cyrus Recapitalization immediately following transactions contemplated by Sections 3.2, 3.3, 3.4, 4 and 5 and on the date of the Pricing. 

9.6 No Transfer of Securities. Each Equityholder hereby covenants and agrees that it shall not transfer any Notes, Related-Party
Pre-IPO Warrants, Preferred Stock, Non-Class-A Common Stock or Common Stock held by it prior to the consummation of the transactions contemplated by Section 3, Section 4 and Section 5. 

9.7 Conflicts with Pre-IPO Transaction Documents. In the event of any conflict between the terms of this Agreement and any
Pre-IPO Transaction Document, the terms of this Agreement shall govern and control. 
 9.8 Termination of Security Agreements and
Intercreditor Agreement. Following the payments and exchanges set forth in Section 3, Section 4 and Section 5, the parties hereto shall terminate the Intercreditor Agreement, the Company’s Sixth
Amended and Restated Stockholders Agreement and the Security Agreements and any related financing statements made under the UCC, and each holder of Notes terminates, releases and discharges, without recourse, all of the Liens on any assets of the
Company created by the Notes. 
 9.9 HSR Matters. All filings required under the HSR Act shall have been made, and any
required waiting period thereunder shall have expired or been earlier terminated, 

  
 17 

 
prior to the consummation of any of the transactions contemplated by Section 3, Section 4 and Section 5. If any filings are required by the HSR Act for any
transactions contemplated by Section 3, Section 4 or Section 5, the Company will cooperate reasonably with the other parties hereto to prepare and make such filings and shall pay for any reasonable out-of-pocket
expenses of such parties made in connection with the preparation and filing of any filings required under the HSR Act. 
 9.10 DOT
Matters. All requirements imposed by the DOT shall have been satisfied prior to the consummation of any of the transactions contemplated by Section 3, Section 4 and Section 5. If any filings are required
by the DOT for any transactions contemplated by Section 3, Section 4 or Section 5, the Company will cooperate reasonably with the other parties hereto to prepare and make such filings and shall pay for any
reasonable out-of-pocket expenses of such parties made in connection with the preparation and filing of any filings required by the DOT. 

9.11 Voting and Cooperation. In order to facilitate the transactions contemplated by this Agreement, each Equityholder hereby
agrees to vote all of such Equityholder’s shares of Capital Stock in favor of any amendments, modifications or waivers of the Company’s certificate of incorporation in order to effect the transactions contemplated by this Agreement. In
addition, each Equityholder agrees to execute and deliver all related documentation and take such other action in support of the transactions as contemplated by this Agreement as shall be reasonably requested by the Company. Each Equityholder that
holds a Note or a Related-Party Warrant as of the date hereof hereby waives any all notice requirements in connection with the repayment, cancellation or exchange of such securities (and any other prior notice requirements provided for in such
securities, including any notice requirements arising from the Reverse Split). 
 10. Representations and Warranties of the
Company. The Company hereby represents, warrants and covenants to the Equityholders that, as of the date hereof, each of the following representations and warranties set forth below in this Section 10 is true and correct. 

10.1 Organization; Powers. The Company is duly organized, validly existing and in good standing under the laws of the
jurisdiction of its organization, has all requisite power and authority to carry on its Business, except where the failure to do so, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect, is qualified
to do business in, and is in good standing in, every jurisdiction where such qualification is required. 
 10.2 Authorization;
Enforceability. This Agreement has been duly executed and delivered by the Company and constitutes a legal, valid and binding obligation of the Company, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency,
reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law. 

10.3 Consents and Approvals; No Conflicts. The transactions contemplated hereby (i) do not require any consent or approval
of, registration or filing with, or any other action by, any Governmental Authority or any other Person, except such as have been obtained 

  
 18 

 
or made and are in full force and effect, where failure to obtain such consent or approval would not reasonably be expected to have a Material Adverse Effect or other than as may be required
under the HSR Act, (ii) will not violate the certificate of incorporation or bylaws of the Company or any order of any Governmental Authority and (iii) will not violate any material Governmental Requirement. 

11. Representations and Warranties of the Equityholders. Each Equityholder, severally and not jointly, hereby, represents,
warrants and covenants to the Company, as of the date hereof, as follows: 
 11.1 Authorization; Enforceability. Such
Equityholder has been duly formed and is validly existing as a legal entity in good standing under the laws of its jurisdiction of organization. Such Equityholder has full power and authority to execute and deliver this Agreement and to perform its
obligations hereunder and to consummate the transactions contemplated hereby. The execution and delivery by such Equityholder of this Agreement, and the performance of its obligations hereunder, have been duly and validly authorized by all necessary
actions of such Equityholder. This Agreement and all other documents referenced herein executed by such Equityholder have been duly and validly executed and delivered by such Equityholder and constitute the legal, valid and binding obligations of
such Equityholder, enforceable against such Equityholder, in accordance with their terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general
principles of equity, regardless of whether considered in a proceeding in equity or at law. 
 11.2 Compliance with Governmental
Requirements and Other Instruments. The consummation of the transactions contemplated by this Agreement and the execution, delivery and performance of the documents referenced herein to which such Equityholder is a party will not
(i) contravene, result in any breach of, or constitute a default under, any charter or bylaws or other organizational documents of such Equityholder, or material agreement or instrument to which such Equityholder is a party, (ii) conflict
with or result in a breach of any of the terms, conditions or provisions of any order of any court, arbitrator or Governmental Authority applicable to such Equityholder, or (iii) violate any provision of any statute or other rule or regulation
of any Governmental Authority applicable to such Equityholder. 
 11.3 Acquisition for the Account of Each Equityholder. Such
Equityholder is acquiring and will acquire all securities to be issued pursuant to this Agreement (and all securities issuable upon exercise or conversion thereof) (collectively, the “Securities”) for its own account, with no
present intention of distributing or reselling such securities or any part thereof in violation of applicable securities laws. Such Equityholder further represents that it does not have any contract, undertaking, agreement or arrangement with any
person to sell, transfer or grant participation to any third person with respect to any of the Securities to be received pursuant to this Agreement. 

11.4 Common Stock Not Registered. Such Equityholder acknowledges that the Securities to be received pursuant to this Agreement
have not been, and when issued will not be, registered under the Securities Act or the securities laws of any state in the United States or 

  
 19 

 
any other jurisdiction and may not be offered or sold by such Equityholder unless subsequently registered under the Securities Act (if applicable to the transaction) and any other securities laws
or unless exemptions from the registration or other requirements of the Securities Act and any other securities laws are available for the transaction. 

11.5 Additional Acknowledgements. Such Equityholder has received and reviewed information about the Company and has had an
opportunity to discuss the Company’s business, management and financial affairs with directors, officers and management of the Company and to review the Company’s operations and facilities. Such Equityholder has also had the opportunity to
ask questions of and receive answers from, the Company and its management regarding the terms and conditions the transactions contemplated by this Agreement. Such Equityholder believes it has received all the information it considers necessary or
appropriate to determine whether to receive the Securities as contemplated by this Agreement. Such Equityholder understands and acknowledges that such discussions, as well as any written information issued by the Company may have contained
forward-looking statements involving known and unknown risks and uncertainties which may cause the Company’s actual results in future periods or plans for future periods to differ materially from what was anticipated and that no representations
or warranties were or are being made with respect to any such forward-looking statements or the probability of achieving any of the results projected in any of such forward-looking statements. 

11.6 Accredited Investor. Such Equityholder represents that it is an “accredited investor” within the meaning of Rule
501 of Regulation D promulgated under the Securities Act, as presently in effect. 
 11.7 Economic Risk. Such Equityholder has
substantial experience in evaluating and investing in securities in companies similar to the Company so that it is capable of evaluating the merits and risks of its investment in the Company, has the capacity to protect its own interests and has the
ability to bear the economic risks of such Equityholder’s investment. Such Equityholder must bear the economic risk of this investment indefinitely unless the Securities are registered pursuant to the Securities Act, or an exemption from
registration is available. 
 11.8 Rule 144. Such Equityholder acknowledges and agrees that the Securities received pursuant
to this Agreement must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. Such Equityholder has been advised or is aware of the provisions of Rule 144
promulgated under the Securities Act as in effect from time to time, which permits limited resale of shares purchased in a private placement subject to the satisfaction of certain conditions, including, among other things: the availability of
certain current public information about the Company, the resale occurring following the required holding period under Rule 144 and the number of shares being sold during any three-month period not exceeding specified limitations. Such Equityholder
understands that no public market now exists for any of the Securities issued by the Company pursuant to this Agreement and that a public market may never exist for the Company’s Capital Stock. 

11.9 Ownership of Securities. Such Equityholder is the sole beneficial and record owner of the Notes and the Related-Party
Pre-IPO Warrants set forth on Schedules A through F attached hereto and has good, clear and marketable title to such securities and all shares of Capital Stock held by such Equityholder, free of any Liens. 

  
 20 

 12. Miscellaneous. 

12.1 Waivers and Amendments. Except as otherwise provided herein, no modification, amendment or waiver of any provision of this
Agreement shall be effective against the Company or the Equityholders unless such modification, amendment or waiver is approved in writing by the Company and the Requisite Equityholders. Any such modification, amendment or waiver given by the
Requisite Equityholders, as applicable, in accordance with this Section 12.1 shall be binding on all Equityholders. 
 12.2
Notices. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified; (b) when sent by confirmed facsimile if sent during
normal business hours of the recipient, if not, then on the next Business Day; (c) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (d) one day after deposit with a nationally
recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the parties at their respective addresses as set forth on the signature pages hereof or at such other address as a
given party may designate by ten days’ advance written notice to the other parties hereto. 
 12.3 Governing Law. THIS
AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF DELAWARE, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW. EACH OF THE PARTIES TO THIS AGREEMENT HEREBY IRREVOCABLY SUBMITS ITSELF AND EACH OTHER
RELATED PERSON TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE STATE OF DELAWARE AND AGREES AND CONSENTS THAT SERVICE OF PROCESS MAY BE MADE UPON IT IN ANY LEGAL PROCEEDING RELATING TO THE THIS AGREEMENT. EACH OF THE
PARTIES HERE IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF THE VENUE OF ANY SUCH PROCEEDING BROUGHT IN SUCH A COURT AND ANY CLAIM THAT ANY SUCH PROCEEDING
BROUGHT IN SUCH A COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.  
 12.4 Waiver of Jury Trial, Punitive Damages,
Etc. Each party hereto hereby: 
 (a) KNOWINGLY, VOLUNTARILY, INTENTIONALLY, AND IRREVOCABLY WAIVES, TO THE MAXIMUM EXTENT NOT
PROHIBITED BY LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, OR DIRECTLY OR INDIRECTLY AT ANY TIME ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR TRANSACTIONS CONTEMPLATED HEREBY OR ASSOCIATED
HEREWITH, BEFORE OR AFTER MATURITY; 

  
 21 

 (b) CERTIFIES THAT NO PARTY HERETO NOR ANY REPRESENTATIVE OR AGENT OR COUNSEL FOR ANY PARTY
HERETO HAS REPRESENTED, EXPRESSLY OR OTHERWISE, OR IMPLIED THAT SUCH PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVERS; AND 

(c) ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY BY, AMONG OTHER THINGS,
THE MUTUAL WAIVERS AND CERTIFICATIONS CONTAINED IN THIS SECTION. 
 12.5 Entire Agreement. This Agreement and the
documents and exhibits referenced herein sets forth the entire understanding of the parties hereto with respect to the subject matter hereof. There are no agreements, representations, warranties, covenants or understandings with respect to the
subject matter hereof or thereof other than those expressly set forth herein and therein. This Agreement supersedes all other prior agreements and understandings between the parties with respect to such subject matter. 

12.6 Assignment; Successors and Assigns. This Agreement shall be binding upon the parties hereto and their successors and
assigns and inure to the benefit of the parties hereto and their successors and assigns; provided, however, that the Company may not delegate or assign any of its obligations hereunder, and any purported delegation or assignment shall be void,
unless the Company has obtained the prior written consent of the Requisite Equityholders to such delegation or assignment, which consent the Requisite Equityholders may provide in their sole and absolute discretion. No Person, other than the parties
hereto and their permitted successors and assigns, shall have any rights hereunder or be entitled to rely on this Agreement and all third-party beneficiary rights are hereby expressly disclaimed. 

12.7 Counterparts. This Agreement and any amendment hereto may be signed in any number of separate counterparts, each of which
shall be deemed an original, but all of which taken together shall constitute one Agreement (or amendment, as applicable). Any signature page delivered electronically or by facsimile (including without limitation transmission by portable document
format or other fixed image form) shall be binding to the same extent as an original signature page. 
 12.8 Severability. In
the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable, the validity, legality and enforceability of any such provision in every other respect and
of the remaining provisions contained herein shall not be affected or impaired thereby. 
 12.9 Specific Performance. The
parties hereto recognizes that money damages may be inadequate to compensate the other parties for a breach of its obligations hereunder, and the irrevocably agrees that the other parties shall be entitled to the remedy of

  
 22 

 
specific performance or the granting of such other equitable remedies as may be awarded by a court of competent jurisdiction in order to afford the parties to this Agreement the benefits of this
Agreement and that each party shall not object and hereby waive any right to object to such remedy or such granting of other equitable remedies on the grounds that money damages will be sufficient to compensate the parties hereto. 

12.10 Further Assurances. The parties hereto will sign such further documents, cause such meetings to be held, resolutions
passed, exercise their votes and do and perform and cause to be done such further acts and things necessary, proper or advisable in order to give full effect to this Agreement and every provision hereof. 

12.11 Restrictive Legends. Each certificate representing Common Stock issued in connection with this Agreement shall be stamped
or otherwise imprinted with a legend substantially in the following form: 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933 OR APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE SOLD, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE
TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT OF 1933 AND APPLICABLE STATE SECURITIES LAWS, OR THE AVAILABILITY OF AN EXEMPTION FROM THE REGISTRATION PROVISIONS OF THE SECURITIES ACT OF 1933 AND
APPLICABLE STATE SECURITIES LAWS. 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND
RESALE, INCLUDING A LOCK-UP PERIOD IN THE EVENT OF A PUBLIC OFFERING PURSUANT TO AN AGREEMENT, COPIES OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE COMPANY. SUCH LOCKUP PERIOD IS BINDING ON TRANSFEREES OF THESE SECURITIES. 

12.12 Withholding. To the extent necessary, the Company shall be entitled to deduct and withhold from any amounts payable to an
Equityholder pursuant to this Agreement, such amounts as the Company is required to deduct and withhold under the Internal Revenue Code of 1986, as amended, or any provision of state, local or foreign tax law with respect to this Agreement. To the
extent that amounts are so withheld and paid over to the appropriate Governmental Authority by the Company, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Equityholder in respect of whom such
withholding was made. The Company shall provide evidence of such payment to such Equityholder. 
 12.13 Effectiveness. This
Agreement shall become effective on the date hereof. Unless otherwise agreed to be the Requisite Equityholders, if the Initial Public Offering is not consummated on or prior to March 31, 2015, then this Agreement shall automatically terminate
and be of no force and effect. 

  
 23 

 12.14 Interpretation. In this Agreement, unless otherwise indicated, the singular
includes the plural and conversely; words importing one gender include the others; references to statutes or regulations are to be construed as including all statutory or regulatory provisions consolidating, amending or replacing the statute or
regulation referred to; references to “writing” include printing, typing, lithography and other means of reproducing words in a tangible visible form; the word “or” shall not be exclusive (i.e., shall be deemed to include
“and/or”); the words “including,” “includes” and “include” shall be deemed to be followed by the words “without limitation”; references to articles, sections (or subdivisions of sections), exhibits,
annexes or schedules are to such parts of this Agreement; references to agreements and other contractual instruments shall be deemed to include all subsequent amendments, restatements, amendments and restatements, supplements, extensions and other
modifications to such instruments (without, however, limiting any prohibition on any such amendments, extensions and other modifications by the terms of this Agreement); and references to Persons include their respective permitted successors and
assigns and, in the case of any Governmental Authority, Persons succeeding to their respective functions and capacities. 
 (Signature Pages
Follow) 

  
 24 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	VIRGIN AMERICA INC.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	Address:
		 	555 Airport Blvd.
		 	Burlingame, CA 94010
		 	Facsimile: (650) 762-7001
		 	Attention: General Counsel

  
 [SIGNATURE PAGE TO
RECAPITALIZATION AGREEMENT] 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	VIRGIN MANAGEMENT LIMITED
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	VX HOLDINGS, L.P.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	VA HOLDINGS (GUERNSEY) LP
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	VIRGIN HOLDINGS LIMITED
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 [SIGNATURE PAGE TO
RECAPITALIZATION AGREEMENT] 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	 CYRUS SELECT OPPORTUNITIES MASTER FUND, LTD.
  

By: Cyrus Capital Partners, L.P., its investment manager

		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	 CYR FUND, L.P.
  

By: Cyrus Capital Partners, L.P., its investment manager

		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	 CRESCENT 1, L.P.
  

By: Cyrus Capital Partners, L.P., its investment manager

		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	 CYRUS OPPORTUNITIES MASTER FUND II, LTD.
  

By: Cyrus Capital Partners, L.P., its investment manager

		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	 CYRUS AVIATION INVESTOR, LLC
  

By: Cyrus Aviation Partners II, L.P., its managing member
  

By: Cyrus Capital Partners GP, L.L.C., its general partner

		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 [SIGNATURE PAGE TO
RECAPITALIZATION AGREEMENT] 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	 CYRUS AVIATION PARTNERS III, L.P.
  

By: Cyrus Capital Partners, L.P., its investment manager

		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	 CYRUS AVIATION PARTNERS IIIA, L.P.
  

By: Cyrus Capital Partners, L.P., its investment manager

		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	 CYRUS AVIATION PARTNERS IV, L.P.
  

By: Cyrus Capital Partners, L.P., its investment manager

		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	 CCP INVESTMENTS I, L.P.
  

By: Cyrus Capital Partners, GP, L.L.C., its general manager

		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	 CRS FUND, LTD.
  

By: Cyrus Capital Partners, L.P., its investment manager

		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 [SIGNATURE PAGE TO
RECAPITALIZATION AGREEMENT] 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	 CM FINANCE INC
  

By: Cyrus Capital Partners, L.P., its investment manager

		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 [SIGNATURE PAGE TO
RECAPITALIZATION AGREEMENT] 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	CYRUS AVIATION HOLDINGS, LLC
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 [SIGNATURE PAGE TO
RECAPITALIZATION AGREEMENT] 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	VAI MBO INVESTORS, LLC
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 [SIGNATURE PAGE TO
RECAPITALIZATION AGREEMENT] 

 Schedule A 

ONPA Notes 
  

					
	 Equityholder
	  	Aggregate Face Amount	 
	 VA Holdings (Guernsey) LP
	  	$	182,439,078.34	  

 Schedule B 

ANPA Notes 
  

					
	 Equityholder
	  	Aggregate Face Amount	 
	 VA Holdings (Guernsey) LP
	  	$	92,588,299.00	  
	 Cyrus Select Opportunities Master Fund, Ltd.
	  	$	1,847,898.13	  
	 CYR Fund, L.P.
	  	$	3,880,586.08	  
	 Crescent 1, L.P.
	  	$	4,434,955.52	  
	 Cyrus Opportunities Master Fund II, Ltd.
	  	$	8,315,541.60	  

 Schedule C 

TNPA Notes 
  

					
	 Equityholder
	  	Aggregate Face Amount	 
	 VA Holdings (Guernsey) LP
	  	$	10,867,741.14	  
	 Virgin Management Limited
	  	$	59,357,903.48	  
	 Cyrus Opportunities Master Fund II, Ltd.
	  	$	2,437,106.73	  
	 Cyrus Select Opportunities Master Fund, Ltd.
	  	$	541,579.27	  
	 CYR Fund, L.P.
	  	$	1,137,316.48	  
	 Crescent 1, L.P.
	  	$	1,299,790.26	  

 Schedule D 

Fourth NPA Notes 
  

					
	 Equityholder
	  	Aggregate Face Amount	 
	 Cyrus Opportunities Master Fund II, Ltd.
	  	$	19,018,838.00	  
	 CYR Fund, L.P.
	  	$	27,300,000.00	  
	 Crescent 1, L.P.
	  	$	24,600,000.00	  
	 Cyrus Select Opportunities Master Fund, Ltd.
	  	$	2,790,000.00	  
	 Cyrus Aviation Partners III, L.P.
	  	$	53,740,631.00	  
	 CCP Investments I, L.P.
	  	$	759,369.00	  
	 Cyrus Aviation Partners IIIA, L.P.
	  	$	16,791,162.00	  
	 CM Finance LLC
	  	$	5,000,000.00	  

 Schedule E 

Fifth NPA Notes 
  

					
	 Equityholder
	  	Aggregate Face Amount	 
	 Cyrus Aviation Partners IV, L.P.
	  	$	23,160,421.00	  
	 CM Finance LLC
	  	$	5,000,000.00	  
	 Cyrus Opportunities Master Fund II, Ltd.
	  	$	9,339,579.00	  
	 Virgin Management Limited
	  	$	37,500,000.00	  

 Schedule F 

Related-Party Pre-IPO Warrants 
  

															
	 Equityholder
	  	Class	  	Exercise
Price per
Share
(before giving effect
to the Reverse Split)	 	  	Shares
(before giving effect to
the Reverse Split)	 	  	Shares
(after giving effect
to the Reverse Split)	 
	 Cyrus Aviation Investor, LLC
	  	A	  	$	0.01	  	  	 	334,837	  	  	 	44,355	  
	 VX Holdings, L.P.
	  	A	  	$	0.01	  	  	 	32,553	  	  	 	4,312	  
	 VAI MBO Investors, LLC
	  	A	  	$	0.01	  	  	 	167,418	  	  	 	22,177	  
	 VX Holdings, L.P.
	  	A	  	$	0.01	  	  	 	23,252	  	  	 	3,080	  
	 VX Holdings, L.P.
	  	C-2	  	$	0.01	  	  	 	1,346,065	  	  	 	178,311	  
	 VX Holdings, L.P.
	  	C-4	  	$	0.01	  	  	 	480,738	  	  	 	63,682	  
	 VX Holdings, L.P.
	  	C-5	  	$	5.00	  	  	 	60,000,000	  	  	 	7,948,140	  
	 Cyrus Aviation Investor LLC
	  	C-6	  	$	5.00	  	  	 	2,105,000	  	  	 	278,847	  
	 Cyrus Aviation Investor LLC
	  	C-7A	  	$	10.00	  	  	 	6,666,667	  	  	 	883,126	  
	 VAI MBO Investors, LLC
	  	C-7B	  	$	10.00	  	  	 	3,333,333	  	  	 	441,563	  
	 Cyrus Aviation Investor LLC
	  	C-8	  	$	15.00	  	  	 	20,000,000	  	  	 	2,649,380	  
	 Cyrus Aviation Investor LLC
	  	C-9	  	$	20.00	  	  	 	30,000,000	  	  	 	3,974,070	  
	 Cyrus Aviation Partners IIIA, L.P.
	  	C-11	  	$	3.50	  	  	 	1,292,919	  	  	 	171,271	  
	 CM Finance LLC
	  	C-11	  	$	3.50	  	  	 	385,000	  	  	 	51,000	  
	 Cyrus Opportunities Master Fund II, Ltd.
	  	C-11	  	$	3.50	  	  	 	247,081	  	  	 	32,730	  
	 Cyrus Opportunities Master Fund II, Ltd.
	  	C-12A	  	$	3.50	  	  	 	2,191,266	  	  	 	290,274	  
	 Cyrus Select Opportunities Master Fund, Ltd.
	  	C-12B	  	$	3.50	  	  	 	386,694	  	  	 	51,224	  
	 CYR Fund, L.P.
	  	C-12C	  	$	3.50	  	  	 	3,783,780	  	  	 	501,233	  
	 Crescent 1, L.P.
	  	C-12D	  	$	3.50	  	  	 	3,409,560	  	  	 	451,661	  
	 Cyrus Aviation Partners III, L.P.
	  	C-12E	  	$	3.50	  	  	 	7,448,451	  	  	 	986,688	  
	 CCP Investments I, L.P.
	  	C-12E	  	$	3.50	  	  	 	105,1249	  	  	 	13,942	  
	 Virgin Management Limited
	  	C-14A	  	$	2.50	  	  	 	14,539,414	  	  	 	1,926,021	  
	 VA Holdings (Guernsey) LP
	  	C-14B	  	$	2.50	  	  	 	140,916,026	  	  	 	18,667,006	  
	 VX Holdings, L.P.
	  	C-14C	  	$	0.01	  	  	 	7,446,931	  	  	 	986,487	  
	 Cyrus Opportunities Master Fund II, Ltd.
	  	C-15A	  	$	2.50	  	  	 	4,736,414	  	  	 	627,428	  
	 Cyrus Aviation Partners IV, L.P.
	  	C-15B	  	$	2.50	  	  	 	2,377,804	  	  	 	314,985	  
	 CM Finance LLC
	  	C-15C	  	$	2.50	  	  	 	513,333	  	  	 	68,000	  
	 Cyrus Select Opportunities Master Fund, Ltd.
	  	C-15D	  	$	2.50	  	  	 	839,456	  	  	 	111,201	  
	 CYR Fund, L.P.
	  	C-15E	  	$	2.50	  	  	 	1,762,857	  	  	 	233,523	  
	 Crescent 1, L.P.
	  	C-15F	  	$	2.50	  	  	 	2,014,694	  	  	 	266,884	  

 Exhibit A 

Form of Virgin Group Post-IPO Note NPA 

 Exhibit B 

Form of Reimbursement Agreement 

 Exhibit C 

Form of Registration Rights Agreement 

 Exhibit D 

Form of Amended and Restated Virgin License

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}]]